Abstract
Osteocytes, the most abundant and long-lived cells in bone, are the master regulators of bone remodeling. In addition to their functions in endocrine regulation and calcium and phosphate metabolism, osteocytes are the major responsive cells in force adaptation due to mechanical stimulation. Mechanically induced bone formation and adaptation, disuse-induced bone loss and skeletal fragility are mediated by osteocytes, which sense local mechanical cues and respond to these cues in both direct and indirect ways. The mechanotransduction process in osteocytes is a complex but exquisite regulatory process between cells and their environment, between neighboring cells, and between different functional mechanosensors in individual cells. Over the past two decades, great efforts have focused on finding various mechanosensors in osteocytes that transmit extracellular mechanical signals into osteocytes and regulate responsive gene expression. The osteocyte cytoskeleton, dendritic processes, Integrin-based focal adhesions, connexin-based intercellular junctions, primary cilium, ion channels, and extracellular matrix are the major mechanosensors in osteocytes reported so far with evidence from both in vitro and in vitro studies. This review aims to give a systematic introduction to osteocyte mechanobiology, provide details of osteocyte mechanosensors, and discuss the roles of osteocyte mechanosensitive signaling pathways in the regulation of bone homeostasis.
Subject terms: Bone quality and biomechanics, Osteoporosis
Introduction
Osteocytes are the most abundant and long-lived cell type in bone, accounting for 90%–95% of total bone cells in the adult skeleton.1 Although osteocytes are terminally differentiated cells derived from osteoblasts, bone contains ten times more osteocytes than osteoblasts.2 Over the last two to three decades, osteocytes, previously seen as a “passive placeholder” in mineralized bone, have emerged as a new multifunctional “superstar” in bone research.1 First, osteocytes are the master regulator of bone homeostasis through their direct regulation of local calcium abundance in mineralization and indirect control of osteoblast (bone-forming cell) and osteoclast (bone-resorbing cell) activities by the secretion of important regulatory factors.3–5 Second, osteocytes are endocrine cells that regulate phosphate metabolism in multiple organs, such as the kidney and parathyroid.1,6–8 Last, but the most importantly, osteocytes function as the principal regulators of bone mechanosensation and mechanotransduction.1,9–11
Mechanical stimuli induce and regulate various cellular functions, such as gene expression, protein synthesis, cell proliferation, and differentiation.12,13 Galileo was a pioneer who observed and described that in bone tissue “loading is required to preserve bone mass.”10 In 1892, the German surgeon Julius Wolff introduced his famous “Wolff’s Law,” stating that bone growth and remodeling occur in response to forces placed upon bone in a healthy person.10,14 In the 1980s, Harold Frost was the first to use the word “mechanostat” to describe the mechanism underlying this load-induced bone adaptation process and identify osteocytes as the “mechanostat” of bone.10,15
During mechanical stimulation from daily activities, whole-body mechanics are transduced to the organ level, tissue level, and finally, cellular level.16 In bone tissue, osteocytes have been suggested to be the main cell type responsive to mechanical stimulation.1,10,16 Direct evidence for the mechanosensitive function of osteocytes was revealed in a study showing that transgenic mice with specific osteocyte ablation failed to respond to unloading-induced bone loss.17 The mechanical environment in the mineralized extracellular matrix (ECM), in which osteocytes are embedded, presents a dynamic combination of various biophysical stimuli, including strain, stress, shear, osmotic pressure, fluid flow, streaming potentials, and acceleration.18 Among these stimuli, the shear stress of fluid flow from loading is the main force stimulation applied to osteocytes.9,16
The essential role of shear stress in osteocytes is determined by the natural physical environment of these cells, with osteocytes embedded in a lacuno-canalicular system (LCS) (Fig. 1). Transmission electron microscopy (TEM) analysis of fine murine bone sections revealed an average distance of 0.7 μm (0.1–2.0 μm) in the osteocyte lacuna, the space between the osteocyte cell body and mineralized ECM.19 A layer of collagen fibrils called the pericellular matrix (PCM), which is distinct from mineralized ECM, surrounds the osteocyte cell body in the lacuna. The PCM has a thickness of 0.5–1.0 μm and does not directly interact with the osteocyte cell surface, leaving a 50–80-nm space between cells and the PCM.20 In the osteocyte canaliculi, the canalicular diameter ranges from 210–260 nm.21,22 Moreover, collagen matrix projections from mineralized substrate form “hill-like” structures in osteocyte canaliculi that directly link the matrix and osteocyte dendrites. These structures are called “collagen hillocks”20 or “canalicular projections,”22 and an average internal space of 130 ± 40 nm exists between two projections.20 At the interface between collagen hillocks and osteocyte dendrites, Integrin-mediated focal adhesions (FAs) link the cell membrane and matrix23 and further transmit physical signals to the osteocyte cytoskeleton.
With their special LCS and extensive cell–matrix connections, osteocytes can sense shear stress from mechanical stimulation. A computational model focused on theoretical strain through the sliding of actin microfilaments over fixed Integrin along osteocyte processes suggests that these abundant connections between the canalicular wall and osteocyte processes can amplify the axial strains applied to osteocytes by two orders of magnitude compared with whole-tissue strain.22 As a result, low tissue strain in bone from daily activities can be greatly amplified at the single-cell level and stimulate follow-up actions in osteocytes.
In this review, three main aspects of osteocyte mechanobiology will be discussed in detail. The first aspect concerns methodologies commonly used in the study of osteocyte mechanobiology. Second, how osteocytes sense and transduce mechanical signals into biochemical signals is still debated in the field. Increasing evidence regarding different aspects of osteocytes suggests that osteocytes utilize various molecular mechanosensors to achieve force adaptation. In this review, the seven major mechanosensors reported so far, osteocyte cytoskeletal components, osteocyte dendrites, FAs, gap junctions (GJs), the primary cilium, ion channels, and the ECM, will be introduced and discussed in great detail (Fig. 1c). Third, several mechanotransduction-associated signaling pathways recently reported in osteocytes will be presented and discussed at the end.
Methodology in osteocyte mechanobiology
To mimic different mechanical stimuli that osteocytes experience under different conditions, various methods to examine osteocyte responses in terms of molecular changes, subcellular deformation and overall bone homeostasis have been developed. Considering the complexity of the physical environment; the diverse stimuli that osteocytes experience; and the different components of certain factors, such as magnitude, frequency, and strain rate, simplified methods have been used both in vitro and in vivo to dissect different biophysical environments and separate individual mechanical stimuli applied to osteocytes. Basically, two major approaches are commonly used in this field.24 One is direct mechanical challenge of intact bone tissue in vivo (Tables 1 and 2), while the other takes advantage of in vitro culture systems and involves subjecting osteocytes to different mechanical stimuli (Table 3).
Table 1.
Animal | Age and gender | Limb | F | Peak force | Cycles | Durations | Brief summary | Ref. |
---|---|---|---|---|---|---|---|---|
Ulna loading | ||||||||
Mice | 16 weeks, male and female | Ulna | 2 Hz | 1.0, 1.2, 1.4, 1.6, 1.8 N | 60 per day | 3 days | Both BV/TV and BFR/BS were lower in Lrp5-KO femora than in their control femora. | 157 |
Mice | 16 weeks, female | Ulna | 2 Hz | 1.90–2.5 N | 120 per day | 3 days, 16 days | Loading induced the strain-dependent increase in bone formation in WT mice, resulting from increases in both mineralizing surface (MS/BS) and mineral apposition rate (MAR). | 30 |
Mice | 17 weeks, male and female | Ulna | 4 Hz | 3.0 and 4.3 N | 10 min (strain rate of 0.1 sec) | 5 days per week for 2 weeks | Loading to peak strains of 2 000 mu epsilon stimulated lamellar periosteal bone formation, but no response endosteally. Loading to peak strains of 3 000 mu epsilon induced a mixed woven/lamellar periosteal response and lamellar endosteal bone formation. | 33 |
Mice | 17 weeks, n/a | Ulna | 4 Hz | 2 N | 2 400 per day | 10 days | After loading, the increase of cortical bone thickness was detected in the ulna of both Frzb-KO and control mice. | 207 |
Mice | 18 weeks, male | Ulna | 2 Hz | 2.7 N | 360 per day | 2 days | Bone-formation rate are in parallel with strain loading intensity; reduced sclerostin expression in osteocytes, particularly in high strain region/midshaft; reduced Sost, Dkk1 mRNA in loading ulnar. | 25 |
Rats | 9 weeks, male | Ulna | 2 Hz | n/a | 1 200 per day | 4–8 days and 11–15 days | Approximately 90% of the strain produced by axial loading occurs as a result of medial-to-lateral bending, with the remainder due to axial compression. | 208 |
Rats | 9 weeks, male | Ulna | 2 Hz | n/a | 1 200 per day | 1–5 and 8–12 days | Least squares regression analysis demonstrated a highly significant linear relationship between the magnitude of the applied load and the degree to which longitudinal growth was reduced. | 209 |
Rats | 27 weeks, female | Ulna | 2 Hz | 17 N | 360 per day | 3 days per week, for 16 weeks | The loaded ulnas exhibited 5.4% and 8.6% greater BMD than the control ulnas in the 360 × 1 and 90 × 4 groups, respectively. BMC was increased by 6.9% and 11.7% in the loaded ulnas of the 360 × 1 and 90 × 4 groups, respectively. | 29 |
Rats | 17 weeks, female | Ulna | 4 Hz | 3.0 and 4.3 N | 10 min | 5 days per week for 2 weeks | The loading-induced periosteal response increased cortical bone area by 21% ± 4% compared with 0.03% ± 0.02% in controls. | 33 |
Rats | 20 weeks, female | Ulna | 4 Hz | 20 N | One single stopping point | n/a | Fatigue loading and microdamage formation: Increased TURNL+/Bax+ cells around microdamage, Increased Bcl-2+ cells 1–2 mm away from microdamage. | 175 |
Rats | 24 weeks, female | Ulna | 2 Hz | 17 N | 360 per day | 2 days | Sost transcripts and sclerostin protein levels were dramatically reduced by ulnar loading. | 25 |
Tibia loading | ||||||||
Mice | 10 weeks, male and female | Tibia | 4 Hz | 11.5 ± 0.3 and 2.3 ± 0.3 N | 1 200 per day | 5 days per week, for 2 weeks | Cancellous BV/TV increased 73% in the loaded tibias relative to control tibias. Mean Tb.Th increased (+75%) while Tb.Sp decreased (−19%). Increased tBMD (+18%) contributed to greater bone mass in the loaded tibias following 2 weeks of compression. | 35 |
Mice | 10 weeks, male | Tibia | n/a | 3 N | 1 200 per day | 5 days per week, for 2 or 6 weeks | The mineral content in both cortical and cancellous bones was enhanced after 6 weeks of loading. Greater responses were found in the cortico-cancellous proximal metaphysis (14%) than the cortical midshaft (2%); bone volume fraction and average trabecular thickness of cancellous bone in the proximal tibia increased after 6 weeks by 15% and 12%, respectively. | 34 |
Mice | 12, 14 weeks, male | Tibia | 0.1 Hz | 12 N | 40 per day | 3 days per week, for 2 weeks | At the periosteum, loading increased the BFR 15.5-fold and the mineralization perimeter (MPm/BPm) 8.5-fold in control mice. | 210 |
Mice | 16 weeks, n/a | Tibia | 2 Hz | 9.3 ± 0.9 N | 60 per day | 5 days per week, for 2 weeks | Parameters of new bone formation (i.e., MAR, BFR, and MS) were significantly higher in WT than in cKO tibias after the 2-week loading regimen, with Het mice falling somewhat in between the other two groups. | 98 |
Mice | 16 weeks, n/a | Tibia | 2 Hz | 9.3 ± 0.9 N | 36 per day | 6 days per week, for 2 weeks | The bone response to external loading is greater in LBD mice than in HBD mice. The high bone density of C3H/HeJ (HBD) mice is related to breed-specific factors other than the response to loading. | 211 |
Mice | 19 weeks, female | Tibia | 10 Hz | 13.5 N | 40 per day | n/a | Different region of loaded tibiae responded to loading with different loading-related increases of new bone formation. Among all regions, region-III reached a 75-fold increase. Moreover, the magnitude of loading-related decrease in the percentage of sclerostin-positive osteocytes mirrored the amount of loading-related osteogenesis. | 212 |
Mice | 13–19 weeks female | Tibia and ulnae | 10 Hz | 12.0 N for tibia and 2.5 N for ulna | 40 per day | 10-s intervals between each cycle, for 2 weeks | In trabecular bone of the proximal tibiae, 2 weeks of mechanical loading sufficient by itself to stimulate an osteogenic response, was associated with a 18.6% increase in percent bone volume in the primary spongiosa, a 31.9% increase in percent bone volume in the secondary spongiosa, and a 13.1% increase in trabecular number and a 15.8% increase in trabecular thickness. | 213 |
Mice | 8, 12, 20 weeks, female | Tibia | 2 Hz | 2–13 N | 40 per day | 10-s intervals between each cycle, for 2 weeks | For 12- and 20-week-old mice, loading induced significant decreases in BV/TV. In contrast, tibiae of younger 8-week-old mice show significant increases in BV/TV, achieved predominantly via increases in trabecular number. | 27 |
Mice | 10, 26 weeks, male | Tibia | 4 Hz | 4.5/9.0 N | 1 200 per day | 1, 2, and 6 weeks | In both adult and young mice, loading at 9 N decreased epiphyseal bone mass with a greater decrease observed in the adult mice compared with the young mice. Bone mass increased by 20% with loading in young mice. | 31 |
Mice | 26 weeks, female | Tibia | 4 Hz | 11.3 ± 0.5, 5.9 ± 0.5, and 1.5 ± 0.6 N | 1 200 per day | 5 days per week, for 2 weeks | After loading, cancellous bone mass increased 54% through trabecular thickening, and cortical area increased 41% through medullary contraction and periosteal expansion. Adult mice were able to respond to an anabolic stimulus and recover bone mass to levels seen in growing mice; however, the adaptive response was reduced relative to that in 10-week-old female mice for the same applied load. | 32 |
Rats | 36 weeks, female | Tibia | 2 Hz | 27, 33, 40, 52, and 64 N | 36 per day | 12 days | Bending strains above a loading threshold of 40 N or about 1 050 mu strain increased both bone-forming surface and the mineral apposition rate and subsequently increased the bone-formation rate as much as six folds. No evidence of increased bone formation was seen for applied strains below 1 050 mu strain. | 170 |
F frequency for loading, Ref. references, n/a not available
Table 2.
Animal | Age and gender | Tail-suspension durations | Brief summary | Ref. |
---|---|---|---|---|
Mice | 6 weeks, male | 3 days or 7 days | Increased Sost mRNA in unloading tibia after 3 days treatment; no significant sclerostin-positive osteocytes detected in unloading groups. | 25 |
Mice | 12 weeks, female | 21 days | Hindlimb bone mineral density decreased 9.2% ± 1.0% in HLU of control group. | 28 |
Mice | 17–21 weeks, female | 14 days | Myonuclear number was not altered during either the suspension or the reloading period in soleus muscle fibers from vehicle-treated or satellite cell-depleted animals. | 36 |
Mice | 5 months, n/a | 10 days | During the unloading period, soleus muscle fiber cross section decreased by 38%. | 37 |
Mice | 14 weeks, male | 28 days | 28 days of HLU-induced serious damages in microstructure and mechanical property of the tibia in WT mice. | 123 |
Mice | 3 months, female | 21 days | HLU-induced significant bone loss, as demonstrated by significant decreases in BV/TV, Tb.N, and Ct.Th and an increase in Tb.Sp. | 169 |
Mice | 4 months, n/a | 3 or 14 days | The soleus muscle/body weight ratio decreased by 41% in WT-HLU 14 days, whereas cross‐sectional area fell by 29% in WT‐HLU 14 days. | 38 |
Mice | 8 weeks, male | 21 days | The mRNA expression of Lcn2 significantly increased in the bones of the suspended hindlimbs with respect to those of the hindlimbs of mice maintained under normal conditions. | 214 |
Rats | 6/8 months, female | 28 days | After a 28-day protocol, disuse group reduced BFR (−92%), a suppression only slightly curbed when disuse was interrupted by 10 min of weight bearing (−61%). In contrast, disuse interrupted by 10 min per day of low-level mechanical intervention normalized BFR to values seen in age-matched controls. | 26 |
Rats | 9/29 months, male | 14 days | Decreases in body weight were observed between the adult (12.2% loss) and old (14.6% loss) rats through 14 days of HLU. Adult rats lost a greater percentage of their hindlimb muscle mass after 2 weeks of HUL compared with the old rats. | 215 |
F frequency for loading, Ref. references, n/a not available, BV/TV bone volume fraction, Tb.N trabecular number, Ct.Th cortical thickness, Tb.Sp trabecular separation, BFR bone-formation rate
Table 3.
Cell type | Shear stress/Pa | Flow type | Flow duration | mRNA changes | Other responses | Ref. |
---|---|---|---|---|---|---|
Primary osteocytes | ||||||
Chicken primary osteocytes | 0.5 | p | 1 h | PGE2↑ | All three cell populations rapidly (osteocytes: within 5 min, osteoblast and osteocyte containing population, periosteal fibroblasts: within 10 min) increased their release of prostaglandins E2 and I2 in response to PFF, but the response by osteocytes was 2–4 times higher than that by osteoblast and osteocyte containing population or periosteal fibroblasts. | 39 |
Chicken primary osteocytes | 0.7 | p | 10 min | PGE2↑ | PFF raises intracellular Ca2+ by an enhanced entry through mechanosensitive ion channels in combination with Ca2+ and inositol trisphosphate-induced Ca2+ release from intracellular stores. | 216 |
Mouse primary calvarial bone cell | 0.70 ± 0.03 | p | 1 h | PGHS-2↑ | Northern blot analysis detected after 1 h of PFF treatment increased PGHS-2 mRNA expression about twofold; more PGE2 was released under PFF condition. | 40 |
Human primary trabecular bone cell | 0.7 | p | 1 h | PGE2↑ | Cultured cells responded to mechanical stress with enhanced release of prostaglandin E2 (PGE2) and I2 (PGI2) by western blot. | 105 |
Human primary bone cells | 0.7 | p | 1 h | Cox-2↑PGE2↑ | One-hour PFF treatment stimulated the release of PGE2 by 3.5 folds and PGI2 by 2.2-fold. PFF also increased the expression of Cox-2 mRNA by 2.9 folds, but did not change Cox-1 mRNA by QPCR. | 217 |
Human primary bone biopsies cells | 0.7 | p | 1 h | NO↑PGE2↑ | The PFF-mediated upregulation of PGE2 release during 24 h of postincubation after 1 h of PFF was significantly reduced in osteoporotic patients compared with six age-matched controls as well as with the whole nonosteoporotic group. | 41 |
Osteocyte-like cell lines | ||||||
Ocy454 | 0.5–2.0 | Un-L | 2 h or 3 days | Rankl↓Sost↑ | Ocy454 cells recapitulated the in vivo response to mechanical unloading with increased expression of Sost (3.4 ± 1.9-fold), Sclerostin (4.7 ± 0.1-fold), and the receptor activator of Rankl/Opg (2.5 ± 0.7-fold) ratio. | 43 |
MLO-Y4 | 0.5–5.0 | o | 1–4 h | Rankl↓Opg↓Cox-2↑ | OFF stimulation simultaneously upregulated the Cox-2 mRNA expression and downregulated the Rankl/Opg mRNA levels. | 42 |
MLO-Y4 | 0.7 | p | 1 h | Rankl/Opg↓Opg↑ MEPE↑ | PFF upregulated MEPE gene expression by 2.5-fold, but not PHEX expression. PFF decreased the Rankl/Opg ratio at 1-h PFF treatment. | 218 |
MLO-Y4 | 16.0 | s | 0.5–2 h | Opg↑ | MLO-Y4 cells plated at lower densities release more PGE2 than cells plated at higher densities. Cell surface biotinylation analysis showed that surface expression of Cx43 was increased by shear stress. | 105 |
MLO-Y4 | 16.0 | s | 0.5–2 h | Cx43↑ | SFF has stimulatory effects on MLO-Y4 cells with early effects on cellular morphology, opening of gap junctions, and redistribution of Cx43 protein and delayed effects on Cx43 protein expression. | 102 |
P pulsating, s steady, o oscillating, Un-L unloading, PFF pulsating fluid flow, SFF steady laminar fluid flow, OFF oscillating fluid flow, PGE prostaglandins, PGHS prostaglandin G/H synthase, COX cyclooxygenase, RANKL receptor activator of nuclear factor kappa-Β ligand, OPG osteoprotegerin, MEPE matrix extracellular phosphoglycoprotein, PHEX phosphate-regulating neutral endopeptidase, NO nitric oxide, CX43 connexin-43, Ref. references
Direct in vivo mechanical stimulation is mainly applied to small experimental animals, such as mice and rats, in which gene manipulation and the recapitulation of mammalian bone features are easy. Both active loading models and unloading models are applied in these animals. To develop models of active loading, experimental animals are maintained under isoflurane- or avertin-induced anesthesia, and one side of either the tibia or ulna is subjected to cyclic mechanical compression under a computationally controlled machine (Fig. 2a, b). The contralateral unloaded limb serves as a control. This cyclic compression somehow mimics the process of force generation from physical activities, such as grabbing, walking or running, and contributes to forces applied to bone osteocytes. Hindlimb unloading (HLU), which focuses on disuse conditions and mimics bone loss induced by trips to space and decreased activity, is also popular in studies. In these experiments, animals are outfitted with a tail harness, and their hindlimbs are suspended within customized cages (Fig. 2c). The mice use their forelimbs to contact the cage floor to obtain food and water, but their hindlimbs remain suspended in the air and lose ground reaction forces. These in vivo animal model systems help us to understand the direct relationship between force application and bone adaptation.
In vivo studies provide strong evidence for “Wolff’s law,” which demonstrates significant bone formation under force application (Table 1)25–27 and bone loss under unloading conditions (Table 2).25,26,28 These in vivo studies further suggest that bone adaptation is dependent on the animal species, animal age, loading site, and magnitude and duration of the force applied (Table 1). For example, considering differences in the mechanical properties of limbs between different species, the average peak force used for ulna loading in rats is ~17 N,25,29 while that used in mice is only 2–4 N.25,30 Moreover, considering the different physical loading forces applied on different limbs within the same species, the average external force applied for mouse tibia loading is ~9–11 N,25,29 while that applied for mouse ulna loading is only 2–4 N.25,30 Moreover, force loading must be kept in a particular physical range for different experimental subjects, and extreme force loading could promote cartilage damage and reduce cancellous bone mass in both young and old mice.31 Furthermore, loading effects vary with age. For instance, compared with 10-week-old (young) female mice, 26-week-old female mice displayed less new bone formation when the same load was applied to the tibia.32 In addition, forces with different magnitudes and durations generate various outcomes. When a peak force of 3 N (a peak strain of 2 000 mu epsilon) was applied to the mouse ulna, only lamellar periosteal bone formation was stimulated, but no endosteal response was observed. Similarly, when with a peak force of 4.3 N (a peak strain of 3 000 mu epsilon) was applied to the mouse ulna, a mixed woven/lamellar periosteal response and lamellar endosteal bone formation were induced.33 Moreover, animals to which tibia loading was applied for 6 weeks showed a more significant enhancement in mineral content in both cortical and cancellous bones compared with that after continuous force application for 2 weeks.34 Interestingly, bone formation from mechanosensory osteocytes seems to be independent of sex. Lynch et al. showed that cancellous bone adaptations to tibia compression in growing male and female mice were comparable.35
While results from in vivo loading and unloading experiments provide strong evidence of bone phenotypes under different force conditions, contributions from other cell types during mechanical loading or unloading and the effects from surrounding tissues during experiments cannot be ruled out.36–38 Therefore, in vitro studies focused on osteocytes, a single cell type, can rule out the influence of other cell types and assess osteocyte mechanobiology in greater detail. In general, two types of osteocytes are commonly used in in vitro loading studies (Table 3). One type is primary osteocytes, which are obtained from bone tissues, such as mouse calvarial bone, the chicken skeleton, or even human trabecular bone, through sequential enzymatic digestion.39–41 The other cell type is osteocyte-like cell lines transformed from primary osteocytes that exhibit immortalization, such as MLO-Y4 cells42 and Ocy454 cells.43 These two cell lines are widely used osteocyte-like cells that express specific osteocyte markers and whose morphology resembles that of primary osteocytes. Several physiologically relevant signaling molecules, including intracellular Ca2+, IP3, cAMP, prostaglandin E2 (PGE2), and nitric oxide (NO), are known to be secreted when osteocytes are supplied with fluid flow in vitro (Table 3). Moreover, cell culture studies can recapture in vivo experimental results, such as increased sclerostin expression under unloading conditions.43 These results demonstrate that in vitro methodology is highly valuable for investigating osteocyte responses to loading and unloading stimulation.
Currently, more advanced technologies, including those performed in in vivo such as three-dimensional (3D) fluorescence imaging,44 ex vivo live calcium recording,45 and in vitro inventions, such as bone chip organ culture,46,47 provide more advanced choices to study osteocyte mechanobiology. Many essential aspects of osteocytes in force adaptation are revealed by in vitro techniques and further demonstrated in in vivo models. We will discuss these methodologies in more detail in the following sections regarding osteocyte mechanosensors and signaling pathways.
Osteocyte mechanosensors
How osteocytes sense external mechanical environments, convert mechanical signals into internal biochemical signals, and eventually transduce these signals into different biological functions remains intriguing. The special cellular components or proteins that carry out this signal transduction are called mechanosensors. Over the past two decades, great efforts have focused on finding these mechanosensors. The results of these studies suggest that osteocytes utilize various mechanosensors to respond to physical stimulation. Here, we will introduce and discuss the seven mechanosensors reported so far in detail.
Cytoskeletons: actin filaments, microtubules, and intermediate filaments
All cells are considered viscoelastic materials that can change shape under mechanical load.48 The origin of the mechanical properties of cells and their responses to extracellular mechanical stimuli are mainly dependent on the cytoskeleton, especially the mechanical properties of the cytoskeleton.49 For osteocytes, three types of cytoskeletal filaments define the cell: actin filaments (F-actin), microtubules (MTs), and intermediate filaments (IFs). The mechanical properties of these cytoskeletal components, together with the filament length, crosslinking geometry, and host binding proteins to the side or at the end of cytoskeletal polymers, determine the mechanical properties of cytoskeletal networks and cells50 (Fig. 3). A computational model based on three cytoskeletal components and cell-ECM connections in osteocytes demonstrated a possible mechanism of mechanotransduction from extracellular mechanical stimuli to nuclear responses.51
Even though three types of cytoskeletal filaments contribute to the mechanical properties of the cell, their functions regarding osteocyte mechanical responses differ. In primary osteocytes derived from chicken embryos, immunofluorescence (IF) staining with antitubulin, antivimentin, and antiactin antibodies suggested that the distribution patterns of these cytoskeletal components differ.52 All three filaments are detected in the osteocyte cell body, but only F-actin is located in osteocyte processes. Two actin-bundling proteins, α-actinin and Fimbrin, colocalize in osteocyte processes. Depolymerization of F-actin using pharmaceutical drug treatment (latrunculin B and cytochalasin D) significantly changed the osteocyte morphology, including the retraction of processes and a decrease in the overall size of the cell body until it was a cytoplasmic rim around the nucleus, leaving the cell membrane with folds and wrinkles. These results reveal the great importance of F-actin in the maintenance of osteocyte morphology, membrane tension and mechanosensory capability.
In addition to F-actin, MTs participate in osteocyte mechanosensation. A more recent study performed by Lyons et al. showed that MTs are involved in calcium flux and sclerostin expression in osteocytes.53 Unlike total MTs, detyrosinated MTs were localized to osteocyte processes and the primary cilium in both primary murine osteocytes and the Ocy454 osteocyte cell line. Intact MTs were found to be required for the response of Ocy454 cells to fluid shear stress (FSS), including calcium flux and the regulation of sclerostin expression. Moreover, the MT network is also essential for flow-induced opening of the Ca2+ channel TRPV4 and Ca2+ influx. During these processes, NADPH oxidase 2 and reactive oxygen species participated in MT-dependent CaMKII kinase activation and sclerostin suppression under FSS conditions. These data suggest the role of MTs in the regulation of calcium channel opening and gene expression during osteocyte mechanotransduction.
Fewer studies have been performed on IFs in osteocytes than on F-actin and MTs. Moorer et al. generated transgenic mice in which Synemin, a type IV IF protein, was globally deleted.54 Synemin-null animals displayed normal development with body weights, body lengths, and tibial lengths comparable with those of control animals. At the age of 14 weeks, male Synemin knockout (KO) mice displayed a dramatic osteopenic phenotype in the trabecular bone and a subtle reduction in the cortical area in the femur bone. Further ELISA and in vitro experiments suggested a significant reduction in osteoblastic bone-formation activity and a reduction in osteoblast number in Synemin-KO mice. Interestingly, the expression of osteoblast-related genes, such as those encoding Runx2 and Osteocalcin (Oc), was increased in primary osteoblasts isolated from Synemin-KO mice. These results suggest the potential role of IFs in the regulation of osteogenesis. Further experiments are required to show the relationship between IFs and osteocyte mechanotransduction.
In short, as the major building blocks in osteocytes, together, these three types of cytoskeletal filaments maintain normal osteocyte morphology and regulate osteocyte responses to mechanical stimulation. Some special structures generated from the osteocyte cytoskeleton, such as the primary cilium generated from MTs and FAs associated with F-actin, have been widely acknowledged as the major mechanosensors in osteocytes. More studies on IFs in osteocytes are required. Even though these types of filaments have different functions in osteocyte biology, it would be interesting to examine the interactions and communication between different types of cytoskeletal filaments in osteocyte mechanobiology.
Dendrites vs the cell body
The feature of osteocytes that most distinguishes them from other bone cells is the tremendous dendritic processes that emerge from the osteocyte cell body (Fig. 1). The cell body and dendrites are similar to other specialized cellular compartments and have been assigned different roles in osteocyte mechanobiology (Fig. 4). Among attempts to locate and specify the mechanosensors in osteocytes, debates regarding where osteocytes sense and respond to mechanical stimulation have been ongoing for years.
Compared with the cell body, the dendritic processes of osteocytes are more inclined to be related to mechanotransduction (Fig. 4b). The formation and elongation of dendrites are highly associated with mechanical stimulation.55 These processes are regulated by a glycoprotein named E11 or Gp38 that is selectively expressed in osteocytes.55 E11/Gp38, also called podoplanin or T1alpha molecule, is highly expressed in the dendritic processes of early osteocytes that have begun to be embedded in osteoid but is not expressed in fully differentiated osteocytes in the mineral matrix. ECM mineralization is proposed to be tightly linked to osteocyte differentiation through the E11/Gp38 protein. On the one hand, the physical properties of the ECM can influence osteocyte differentiation by regulation of E11/Gp38 expression.56 On the other hand, mechanical strain both in vitro and in vivo increases E11/Gp38 expression in osteocytes.55 The fluid flow shear stress-induced elongation of dendritic processes in MLO-Y4 cells requires E11/Gp38. However, increased E11/Gp38 expression under mechanical stimuli is not beneficial under certain conditions. Increased E11/Gp38 expression in osteocytes was observed in human and canine osteoarthritic (OA) subchondral bone,57 which resulted in subchondral bone thickening and served as an early detectable marker in osteoarthritis (OA) joints. Moreover, conditional deletion of E11/Gp38 in mature osteoblasts and osteocytes (OC-Cre; E11fl/fl) prevented mechanical load-induced articular cartilage lesions.57 Together, these data suggest that E11/Gp38 participates in osteocyte differentiation and mineralization and that E11/Gp38-associated dendritic process growth is involved in osteocyte mechanotransduction.
In addition to these studies focused on osteocyte dendrite generation, several research groups have utilized different methodologies to directly examine differences in the responses of the cell body and dendritic processes under mechanical stimuli (Fig. 4a). Burra et al. generated a transwell filter system on which MLO-Y4 cells were cultured.58 Due to its specific 1-μm pore size, the filter system in this system could separate the MLO-Y4 cell body and dendritic processes. When fluid droplets were applied to the cell body side or the dendritic side, different parts of the cultured cells experienced mechanical stimulation. Interestingly, when mechanical loading was applied to either the dendrites or the cell body, opening of the hemichannels on the cell body was induced, but the hemichannels on the dendritic side showed no significant activity under either treatment. Moreover, when the glycocalyx on the dendritic side was disrupted by hyaluronidase, hemichannel opening on the cell body was completely blocked. IF staining showed reduced Integrin α5 intensity on osteocyte dendrites after hyaluronidase treatment. These observations suggest that the hemichannels on the cell body side are the channels responsive to mechanical stimulation and that mechanical stress applied to cell dendritic processes requires strong Integrin-based attachment to the extracellular glycocalyx. This Integrin–glycocalyx interaction along osteocyte processes works as a mechanosensor that transmits mechanical signals from cell dendrites to the cell body and leads to the opening of hemichannels (please see below).
Another research team utilized a local fluid stimulation approach to investigate the relationship between cell dendrites and the cell body in response to mechanical force in osteocytes.59,60 This approach uses what is called a Stokesian fluid stimulus probe, which can generate local fluidic stimulation of 1–5 pN without physical contact with the examined cells. Thi et al. presented direct evidence that mechanical force stimulation of dendrites, but not the cell body, activate directional calcium flow in osteocytes.60 Preincubation with a nonpeptide small-molecule ανβ3 Integrin antagonist or an extracellular ATP scavenger (Apyrase, an enzyme that hydrolyzes ATP to AMP) reduced the amplitude and percentage of cellular Ca2+ responses. In addition, Wu et al. showed that focally applied pN-level forces initiated rapid and transient intercellular electrical signals in cultured MLO-Y4 cells.59 This electrical signal was triggered at Integrin attachment sites along both appositional and distal unopposed cell processes but was not initiated at osteocyte cell bodies. This electrical coupling required the presence of ATP released by the stimulated cells, and its strength was increased with increasing numbers of junctional connections, which have been reported to be regulated by Cx43 (detailed information about Cx43 will be discussed in the following section).
Due to the efforts from these brilliant research groups, it is now well accepted that environmental mechanical stimuli sensed by osteocytes are largely relayed through the dendritic processes of osteocytes rather than osteocyte cell bodies (Fig. 4). Osteocytes utilize dendritic processes to receive mechanical signals, transduce these signals through the F-actin and MT cytoskeleton or electrical or calcium signals, and initiate nuclear responses to regulate the expression of target genes (e.g., Sost) or initiate responses from certain subcellular organelles with secondary messenger (e.g., Ca2+ and ATP) activation. It would be interesting to compare osteocyte processes and neuron dendrites. In neurons, signal transmission both in a single neuron and within neuronal networks occurs in a highly organized and directional manner through certain physical functions.61 It would be worth testing whether osteocytes respond to mechanical stimulation with similar directional signal transduction through their processes.
Primary cilia
Cilia are located on the surfaces of almost all mammalian cells.62 The typical structure of the cilium consists of a central MT-based axoneme that emerges from a centriole-derived, MT-organizing center called the basal body and extends from a specialized plasma membrane into the extracellular space.62 Unlike other types of cilia, the primary cilium is a special, solitary organelle that projects from the surface of certain cells. The primary cilium consists of nine doublet MTs but lacks the central pair of MTs needed to generate motile force; the axoneme thus adopts a “9 + 0” pattern.62,63 The axoneme is formed and maintained by intraflagellar transport (IFT) complexes that are trafficked through the ciliary axoneme by the molecular motors anterograde kinesin-II and retrograde dynein 2.63,64 During the cell cycle, the primary cilium can be reabsorbed before the cell enters mitosis and reformed through acetylation of α-tubulin when the cell enters the quiescent G0/G1 stage.64 Since primary cilia exhibit special structural features and directly contact the extracellular environment, it is widely believed that the primary cilium plays pivotal roles in chemosensation and mechanosensation.65
In the bone tissue environment, the primary cilium has been found in large groups of cells, such as bone-derived mesenchymal stem cells (MSCs), tenocytes, chondrocytes, and osteocytes.65 In human bone-derived MSCs, disruption of the primary cilium with Polaris (an IFT-associated protein) siRNA treatment reduced mechanically stimulated Cyclooxygenase-2 (Cox-2) and Bone morphogenetic protein 2 (Bmp2) mRNA expression.66 During chondrocyte development, conditional deletion of Smad1/5 in chondrocytes altered the 3D orientation of the primary cilium without affecting the primary cilium length.67 As a result, misorientation of the primary cilium further affected chondrocyte cell positioning during cell division, caused the misalignment of chondrocytes in columns, and eventually resulted in disorganized growth plates in Smad1/5 conditional KO (cKO) mice.67
In osteocytes, the primary cilium is an important sensor for the responses to mechanical stimulation and coordinates loading-induced bone adaptation65 (Fig. 5). In cultured primary osteoblasts, osteocytes and related cell lines, cilia-like structures were detected through α-Tubulin immunostaining under scanning electron microscopy (SEM).68 These structures are colocalized with the ciliary proteins PC1/polycystin-1, PC2, Tg737, and Kif3a (Fig. 5a). In cultured confluent preosteoblast-like MC3T3-E1 cells and osteocyte-like MLOY4 cells, these cilia-like structures had lengths ranging from 2 to 4 μm.68 In a similar study, primary cilia 4–9 μm in length were reported on the apical surface of ∼61% of MC3T3-E1 cells and ∼62% of MLO-Y4 cells.69 This difference in length may result from different culture conditions and passage numbers.
In addition to in vitro culture conditions, direct observation of the osteocyte primary cilium in bone samples has been achieved in vivo. In a study focused on osteocyte centrosomes and cilia in the adult (6–7 months old) rat tibial cortical bone, positive staining for acetylated α-tubulin (Aα-Tub) was observed in 94% of the osteocytes under confocal microscopy.70 This positive staining for Aα-Tub, which indicates the primary cilium, primary cilium-related zone, or centroids, was mainly oriented perpendicular to the long axis of the bone. In this study, Uzbekov et al. analyzed TEM recordings of primary cilia from ultrathin (70-nm) bone sections. Rather than a clear and distinct primary cilium structure, Uzbekov et al. observed primary cilia at only the initial stages formation, named “cilium membrane prolongation (CMP)” (Fig. 5b). The presence of this CMP structure indicates morphological changes of the cell membrane where the mother centriole contacts the plasma membrane, and a very short axoneme was associated with a cilium-like protrusion.70 Another study of trabecular bone from the cervical vertebrae of young sheep (6–8 months old) found that primary cilia were widespread in bone samples (marrow space, endosteal surface, mineralization matrix).71 Unlike the results of a previous study, only 4.04% ± 1.04% of osteocytes examined in this study presented primary cilia, which were located in the lacunae adjacent to the osteocyte nucleus. With Aα-Tub staining and confocal imaging from sheep bone samples, the measured cilia in osteocytes were found to be 1.62 μm in length on average (Fig. 5b), whereas cilia within the marrow could reach up to 7 μm in length. Discrepancies in primary cilium length and frequency between in vitro and in vivo samples could result from different extracellular environments (2D culture vs LCS), cellular status (immortalized cells vs primary cells), and even sample preparation procedures.70 Considering these discrepancies and the difficulties of in vivo primary cilium studies, more efforts are required to achieve better in vivo imaging results to assess the primary cilium under physiological conditions.
Primary cilia have been demonstrated to participate in osteocyte mechanotransduction both in vitro and in vivo. Under culture conditions, primary cilia were reflected in the direction of steady flow of 0.03 Pa and recoiled after cessation under live imaging.69 Disruption of the primary cilia structure through either chloral hydrate treatment or Polaris siRNA in both the MC3T3-E1 and MLO-Y4 cell lines reduced cellular responses to flow, which included reductions in mechanically induced Opn mRNA expression, extracellular PGE2 levels and the Opg/Rankl mRNA ratio.69 However, these treatments for cilia dysfunction caused no changes in cellular calcium flux in MLO-Y4 or MC3T3-E1 cells. Furthermore, MLO-Y4 cells rapidly responded to 1 peak shear stress oscillatory flow of 1 Pa (1 Hz) and exhibited intracellular cAMP levels reduced to 50%–60% in the first 2 min, and then increased to a 1.5-fold higher level after 30 min.72 These responses were reversed by Adenylyl cyclase 6 (AC6) siRNA, similar to the effects of Polaris siRNA. AC6 is a GTP-dependent enzyme responsible for catalyzing the conversion of cAMP from ATP. AC6 was found to localize to the primary cilium in MLO-Y4 cells. Moreover, AC6 is a calcium ion-inhibited isoform of adenylyl cyclase. Depletion of stored intracellular calcium through thapsigargin treatment had no effect on the flow-mediated decrease in cAMP in MLO-Y4 cells. However, blockade of extracellular Ca2+ entry through membrane-bound channels using GdCl treatment prevented the flow-mediated decrease in cAMP.72 Together, these data suggest that primary cilia influence osteocyte cellular responses to external shear stress through regulating the intracellular cAMP level and extracellular calcium entry independent of intracellular calcium signals.
In addition to in vitro studies, several groups have investigated the function of primary cilium proteins in transgenic animals (Table 4). Because the primary cilium is indispensable for early development, global deletion of Polycystin-1/Pkd, a transmembrane protein component of the ciliary mechanosensory complex encoded by the Pkd1 gene, or inactivating missense mutations of the Pkd1 gene (Pkd1m1Bei/m1Bei) resulted in embryonic lethality in mice.68 Further phenotypic examination showed that Pkd1m1bei/m1bei homozygous mice displayed delayed endochondral and intramembranous bone formation with reduced Runx2 expression. Heterozygous (Pkd1+/m1bei) mice showed reduced mineral density, a reduced mineral apposition rate, and reduced expression of osteoblast-related genes encoding Oc, Osterix (Osx), Opg, and Rankl and the osteoclast marker tartrate-resistant acid phosphatase. Moreover, another important cilia-related protein, Sperm flagellar protein 2 (Spef2), is also involved in the bone-formation process.73 Compared with control mice, Spef2-KO mice had significantly shorter tibiae and femora, with reduced skull bone thickness at P15, lower bone density for both the trabecular and cortical bone of the vertebrae and distal femur, and decreased mechanical properties. Further examination showed that osteoblast differentiation was impaired in Spef2-KO mice, with decreased expression levels of Alp, Runx2, Col1, and Oc (Fig. 5b). Together, these data demonstrate the importance of the primary cilium in bone development.
Table 4.
Targeted cells | Genotype | Baseline skeletal phenotype | External stimulation | Ref. | |
---|---|---|---|---|---|
Mechanical | Chemical | ||||
Global | |||||
Pkd1−/− | Embryonic lethal. | n/a | n/a | 68 | |
Pkd1m1Bei/miBei | Embryonic lethal; delayed endochondral and intramembranous bone formation through inhibition of Runx2 expression. | n/a | n/a | 68 | |
Pkd1+/m1bei | Reduced mineral density, mineral apposition rate, reduced osteoblast marker expression (Osteocalcin, Osterix, Opg, Rankl), osteoclast marker expression (TRAP). | n/a | n/a | 68 | |
Spef2−/− | Significantly shorter tibiae and femora length, with reduced skull bone thickness at P15, lower bone density for both trabecular and cortical bone (Th10 and L2 vertebrae and distal femur), and lower mechanical properties; osteoblast differentiation is impaired in the Spef2-KO mice with lower Alp, Runx2, Col1, and Osteocalcin expressions. | n/a | n/a | 73 | |
AC6−/− | Normal bone morphology. | Impaired responses to mechanical loading; mice lacking AC6 had 41% lower bone formation compared with control animals; primary bone cells isolated from AC6-null mice had an attenuated flow induced increase in Cox-2 mRNA expression. | Similar bone formation in responses to osteogenic chemical agents (PTH). | 76 | |
Osteoblasts and osteocytes | |||||
Cola1(I) 2.3-Cre; Kif3afl/fl | No differences in embryo size, limb patterning, nor growth plate architecture at E16.5–18.5, and even no effect on skeletal morphology, bone density, nor bone quality in adult animals. | Skeletally mature (16 weeks old) Cola1(I) 2.3-Cre; Kif3afl/fl mice exhibit less responsiveness to mechanical ulna loading compared with control mice; displayed significant less bone formation in dynamic histomorphometry analysis. | n/a | 74 | |
OC-Cre; Kif3afl/fl | Developed osteopenia by 6 weeks of age; reductions in femoral bone mineral density (22%), trabecular bone volume (42%) and cortical thickness (17%); impaired osteoblast function. | n/a | n/a | 75 |
Ref. references, n/a not available
To investigate the specific function of the primary cilium in skeletal cells, transgenic mice expressing tissue-specific Cre recombinase were used. Temiyasathit et al. used Cre recombinase driven by the 2.3-kb Collagen1α(I) promoter to delete Kif3a, an IFT protein required for ciliogenesis, in osteoblasts and osteocytes.74 Surprisingly, Cola1(I)-Cre; Kif3afl/fl transgenic mice showed no marked abnormalities in embryo size, limb patterning, or growth plate architecture at E16.5–18.5 or skeletal morphology, bone density, or bone quality as adults. Similar to this study, Qiu et al. conditionally deleted Kif3a in osteoblasts by using Oc-Cre,75 which is thought to be expressed in mature osteoblasts. Compared with control cells, primary osteoblasts derived from Oc-Cre; Kif3afl/fl mice exhibited significant reductions in primary cilia number (by 51%) and length (by 27%) in vitro. Moreover, these Oc-Cre; Kif3afl/fl mice developed osteopenia by 6 weeks of age, unlike Oc-Cre; Kif3afl/+ and Kif3afl/fl control mice. The osteopenic phenotypes included reductions in femoral bone mineral density (BMD) (22%), trabecular bone volume (42%), and cortical thickness (17%). In addition, the loss of bone mass in Oc-Cre; Kif3afl/fl mice was associated with impaired osteoblast function in vivo, as evidenced by a 54% reduction in mineral apposition rate and decreased expression of Runx2, Osx, Oc, and Dmp1. Interestingly, these differences in bone density between cKO and control mice decreased as the animals grew older, as reported in both studies.74,75 The effects of gene deletion at different time frames in osteoblasts and osteocytes suggest that the functions of Kif3a in the primary cilium are required for osteoblast maturation in bone development.
Aside from its roles in bone development, the primary cilium of osteocytes is also tightly associated with mechanotransduction. Even though Cola1(I)-Cre; Kif3afl/fl mice, as discussed above, showed normal skeletal development, skeletally mature (16-week-old) Cola1(I)-Cre; Kif3afl/fl mice exhibited less responsiveness to mechanical ulna loading than control mice.74 These animals with primary cilium dysfunctions displayed significantly less bone formation by dynamic histomorphometry analysis. Similarly, mice with global AC6 KO exhibited a normal bone morphology and similar bone formation in response to an osteogenic agent (PTH) but impaired responses to mechanical loading.76 After ulnar loading over 3 consecutive days, mice lacking AC6 exhibited 41% less bone formation than control animals. Moreover, primary bone cells isolated from AC6-null mice showed an attenuated flow-induced increase in Cox-2 mRNA expression. Together, these in vivo data suggest that an intact primary cilium in osteocytes is required for proper responses to mechanical stimuli.
Over the past decade, more than a dozen disorders in the human population have been reported to be associated with defective ciliary machinery. These primary cilium-related diseases are named ciliopathies.64 Ciliopathies affect nearly every major organ and tissue, including the kidney, brain, limb, retina, liver, and bone.64 Among ciliopathies, skeletal ciliopathies, such as ATD (Jeune syndrome) and Ellis–van Creveld syndrome, are caused by mutations in MT-associated motors, basal body proteins or transport proteins in primary cilia.64 Recently, a skeletal dysfunction named idiopathic scoliosis (IS), a complex pediatric disease of unknown cause that is characterized by abnormal spinal curvature, was reported to be related to abnormalities in the primary cilium. Primary osteoblasts isolated from IS patients showed significantly elongated primary cilia.77 Among cultured primary osteoblasts from both IS patients and healthy donors, the average length of the primary cilium was ~2.6–2.8 μm in IS patients compared with 1.9–2.2 μm in the ilia of healthy donors, whereas the percentages of ciliated cells in control and patient samples were similar. Moreover, when these primary osteoblasts were subjected to physiologically relevant shear stress (1 Hz, 1 Pa), compared with cells from healthy donors, cells from IS patients showed reduced expression of Integrin β1 and Bmp2 and decreased production of Cox-2 induced by mechanical stimulation.
Together, observation of the cilium structure in osteocytes from transgenic mice with bone defects and the severe phenotype of bone-related ciliopathies indicate the significance of the primary cilium in development and mechanical-related bone homeostasis. However, more direct and convincing evidence for morphological changes of the osteocyte primary cilium under both physiological and pathological conditions is urgently needed.
FAs: integrins
Cells sense neighboring microenvironments and nanoenvironments through the FA complex, an Integrin-based adhesion complex.78 As the central proteins in the FA complex, Integrins are transmembrane receptors whose extracellular domain connects with the ECM and cytoplasmic domain is linked to FA-associated proteins that are further linked to the cytoskeleton.79 Integrin-based FA protein complexes help cells explore and respond to different environmental cues, including the chemical and physical properties of the surrounding matrix and mechanical forces applied directly or indirectly to cells. The complexity and modular nature of different adhesion proteins allow cells to respond differently based on extracellular environment changes.
Integrins are heterodimers formed by α and β subunits: the α subunit is responsible for extracellular ligand specificity, while the β subunit contributes to internal signaling pathways.79 A total of 24 αβ heterodimeric Integrin family members have been reported so far, and these Integrins are differentially expressed in different tissues based on the various ECM proteins in the tissue environment.79 In skeletal tissue, Integrins are ubiquitously expressed in multiple bone cells, including bone marrow stem cells, osteoblasts, osteocytes, and osteoclasts.23,80–82
Two major β Integrin subunits, β1 and β3 Integrin, are found in osteocytes.23 Integrin β1 associates with the α1, α2, α3, α4, and α5 Integrin subunits, and Integrin β3 is mainly associated with αv Integrin in osteocytes (Fig. 4). Direct observation from immunohistochemistry (IHC) of bone sections showed that Integrin β1 is mainly found on the osteocyte cell body, whereas Integrin β3 is primarily observed on cell processes.20 Even though Integrin β1, which located on the cell body, is more abundant in osteocytes, Integrin β3, which is associated with processes, exhibits more special features. TEM imaging of bone sections showed that Integrin β3 forms distinct puncta along osteocyte processes localized to specialized membrane protrusions.20 These protrusions along osteocyte processes are in direct contact with the walls of canaliculi, where the canaliculi have projections that contact ECM collagen and glycocalyx. Unlike traditional FA complexes, these β3 Integrins form atypical FA complexes at these contact points. In a study combining IHC with structural illumination by super-resolution microscopy, Cabahug-Zuckerman et al. examined the spatial correlation between Integrin β3 and other proteins in authentic osteocytes in situ.83 Large FA proteins, such as vinculin and paxillin, were detected around the cell body but not on the processes. Instead, a specialized mechanotransduction complex was observed on the osteocyte processes. This complex included the purinergic channel pannexin 1, the ATP-gated purinergic receptor P2X7R and the low-voltage transiently opened T-type calcium channel CaV3.2–1, all of which reside in close proximity to Integrin β3 attachment foci. In summary, Integrin β1 forms a traditional FA complex with Vinculin and Paxillin at the osteocyte cell body (Fig. 4a), while Integrin β3 is distributed with special channel proteins along osteocyte processes (Fig. 4b).
The distinct distributions of Integrins β1 and β3 on osteocytes suggests the different contributions of Integrin β subunits to osteocyte biology. Particular focus has been given to the individual functions of Integrins β1 and β3 in bone development and force adaptation.23,82,83
Studies have shown that both Integrins β1 and β3 are essential for the mechanotransduction of cultured osteocytes. When MLO-Y4 cells were stably transfected with vector expressing a dominant-negative isoform of the β1 subunit (β1DN) containing only the transmembrane domain and cytoplasmic tail of Integrin β1, the cells had reduced vinculin localization to FA complexes.84 Moreover, in response to oscillatory fluid flow, cells expressing β1DN showed significant reductions in fluid flow-induced Cox-2 gene expression and PGE2 release and lost the capability to show a fluid flow-induced decrease in the Rankl/Opg ratio. Intriguingly, cells expressing β1DN showed no alteration in mechanically induced intracellular calcium mobilization. Controversially, another study showed that preincubation with a nonpeptide small-molecule Integrins ανβ3 antagonist (IntegriSense 750) or extracellular ATP scavenger (Apyrase, an enzyme that hydrolyzes ATP to AMP) reduced both the amplitude and percentage of Ca2+ responses.60 Moreover, following the blockade of Integrin β3 or Integrin ανβ3 activity with the corresponding antagonist at 30 min before the application of oscillatory fluid flow, MLO-Y4 cells displayed reduced cell spreading with process retraction, reduced Cox-2 expression, and low PGE2 release with normal expression of Rankl and Opg.85 These results suggest that Integrins β1 and β3 participate in osteocyte FA complex formation and mechanosensation, which may be independent of calcium flux.
In vivo, Integrin β1 has been shown to play inevitable roles in embryogenesis and bone development (Table 5). Global inactivation of Integrin β1 in mice resulted in embryonic lethality due to dysfunctions of the inner cell mass and collapsed blastocoeles.86 Moreover, Integrin β1 was also found to be required for MSC differentiation. Mice with conditional deletion of Integrin β1 in mesenchymal condensation cells using Twist2-Cre transgenic mice did not survive beyond birth.87 These Twist2-Cre; Integrin β1fl/fl mice had impaired skeletal development, especially in the craniofacial and vertebral tissues, at E19.5. In addition, conditional deletion of Integrin β1 in preosteoblasts using Osx-Cre transgenic mice resulted in viable mice that were normal at birth but displayed early defects in calvarial ossification, incisor eruption and growth.87Osx-Cre; Integrin β1fl/flmice had reduced BMD, abnormal bone structure, and defects in mechanical properties. Although these defects persisted into adulthood, they became milder with age.
Table 5.
Targeted cells | Genotype | Baseline skeletal phenotype | Mechanical stimulation | Ref. |
---|---|---|---|---|
Global | ||||
Integrin β1−/− | Embryonic lethality (dysfunctions of inner cell mass and collapsed blastocoeles). | n/a | 86 | |
Integrin β3−/− | No reported skeletal phenotype. | n/a | 90 | |
Mesenchymal condensation cells | ||||
Twist2-Cre; Integrin-β1fl/fl | Die at birth; impaired skeletal development, especially in the craniofacial and vertebral tissues at E19.5 stage. | n/a | 87 | |
Preosteoblasts | ||||
Osx-Cre; Integrin-β1fl/fl | Normal at birth but displayed early defects in calvarial ossification; lower bone mineral density and abnormal bone structure at adult stage; defects in mechanical properties. | n/a | 87,113 | |
Mature osteoblasts and osteocytes | ||||
OC-Cre; Integrin-β1fl/fl | No effect on mineral density, biomechanics or fracture healing, just with some minor alterations of femur structure. | n/a | 87 | |
Cola1(I)2.3-Cre; Integrin-β1fl/fl | No observable skeletal phenotype at the proximal tibia, the distal femur, or lumbar vertebrae; reduced cell dendrites in cortical osteocytes. | Challenged with three consecutive days of cyclic ulna loading, a significant reduction in bone-formation rates was observed at the ulnar midshaft, compared with floxed Integrin-β1fl/fl control mice | 88 | |
Integrin β1-DNOC | Reduced bone mass; increased cortical porosity in long bones, thinner flat bones in the skull; abnormal canaliculi structure in β1-DN mice, together with a higher staining for osteoclasts. | n/a | 89 |
Ref. references, n/a not available, OC osteocalcin
Compared with its essential role in early bone development, the expression of Integrin β1 in mature osteoblasts and osteocytes seems to be more related to osteocyte mechanosensation. Conditional deletion of Integrin β1 in mature osteoblasts and osteocytes using Oc-Cre transgenic mice caused only minor alterations in femur structure without affecting BMD, biomechanics, or fracture healing.87 Similarly, deletion of Integrin β1 using the 2.3-kb Col1a1-Cre caused no observable skeletal phenotype at the proximal tibiae, distal femurs, or lumbar vertebrae.88 However, transgenic mice overexpressing β1DN driven by the Oc promoter showed reduced bone mass, increased cortical porosity in the long bones and thinner flat bones in the skull.89 Detailed examination of these mice further showed an abnormal osteocyte canaliculi structure with increased osteoclast formation in the β1-DN mice. These inconsistent results may reflect the difference in KO and overexpression methodologies used to generate the transgenic mice, and β1DN overexpression have generated stronger effects on Integrin β1-associated signaling cascades. Interestingly, when Cola1(I)-Cre; Integrin β1fl/fl mice, which had a normal skeletal appearance, were challenged with cyclic ulna loading for three consecutive days, a significantly reduced bone-formation rate at the ulnar midshaft compared with that in floxed Integrin β1fl/fl control mice was observed.88 Together, these data suggest that Integrin β1, through its expression in MSCs and early osteoblast-lineage cells, plays a critical role in the regulation of embryogenesis and bone development. Moreover, the function of Integrin β1 in bone formation in mature osteoblasts and osteocytes is limited, but Integrin β1 plays important roles in osteocyte mechanobiology.
Compared with the number of in vivo studies focused on Integrin β1, fewer studies have examined Integrin β3 in bone and osteocytes (Table 5). Even though Integrin β3 has been shown specifically localize to osteocyte processes, where these cells sense external mechanical stimuli, no skeletal defects were reported in global Integrin β3-deficienct mice.90 More investigations are required to demonstrate the possible roles of Integrin β3 in bone and bone adaptation to mechanical stimulation.
Taken together, both in vitro and in vivo data suggest the essential functions of Integrins in bone development and mechanical stimulation-associated bone homeostasis. The results demonstrate that Integrin β1 is important for early osteogenesis, such as that in bone marrow-derived MSCs and osteoblasts during cell differentiation. Since Integrin β3 is localized to the cell processes of osteocytes and directly contacts the canalicular wall, it could be important for osteocyte mechanotransduction. There could be functional redundancy between these two major β Integrins in osteocyte mechanotransduction, which could explain the normal skeletal phenotype in Integrin β1 cKO transgenic mice. Therefore, there is an urgent need for more in vivo studies to show the involvement of Integrin β3 in bone development and bone mechanotransduction.
GJs: connexins
In addition to cell-ECM connections through the FA complex, cells communicate with neighboring cells and the environment through GJs and hemichannels.91 GJs have been widely observed in various organs and systems, including epithelial tissue, eyes, ears, heart, nerve system, and skeletal system. Both GJs and hemichannels are composed of a protein known as connexin. A hexameric array of six connexin subunits gives rise to a connexon. Connexons can be composed of the same type of connexins (homomeric) or different types of connexins (heteromeric). GJs are composed of two juxtaposed connexons on the surfaces of adjacent cells, and unopposed connexons called hemichannels at the cell membrane act as direct conduits between the cytosol and extracellular environment.92 These intercellular and cell-extracellular environment channels allow the direct exchange of ions, nucleotides, small molecules and second messengers (those less than ~1.2 kDa in size, such as ATP, prostaglandin, and IP3).91,92
In the skeleton, GJs are present in all cell types and particularly abundant in osteoblasts and osteocytes.92 Osteoblasts and osteocytes express multiple types of connexins, including Cx40, Cx43, Cx45, Cx46, and Cx37, among which Cx43 is a highly expressed GJ protein in bone.92 Cx43 and other connexins form a functional “3D syncytium” that connects different cells throughout the bone.55 Gap junctional intercellular communication (GJIC) orchestrates the formation and turnover of bone under physiological and pathological conditions.91,93 In particular, Cx43 regulates osteoblast formation, differentiation, survival and apoptosis. Cx43 also participates in the regulation of osteoclast formation and resorption ability. In osteocytes, Cx43-dependent GJIC and hemichannels contribute to the coordination of bone remodeling in response to anabolic factors and mechanical loading (Fig. 6).
Cx43 is vital for animal embryogenesis and bone development. Global deletion of Cx43 in mice resulted in both neural crest cell defects and osteoblast dysfunctions, leading to animal death immediately after birth.94Cx43−/− mice showed delayed intramembranous and endochondral ossification of the cranial vault and long bones during embryogenesis with skeletal abnormalities in the clavicles, ribs, vertebrae, and limbs. Cultured primary osteoblasts derived from Cx43−/− mice exhibited decreased dye coupling compared with that of cells derived from wild-type (WT) control mice. Moreover, Cx43 is involved in aging-related bone loss.95 Aged C57BL/6 mice displayed reduced Cx43 expression in the bone, which was associated with increased osteocyte apoptosis, increased osteoclast number and enhanced bone resorption on the endocortical bone surface. Furthermore, mice carrying a G60S mutation in Cx43 exhibited severe bone mass loss and decreased strength, highly similar to the symptoms of the human disease oculodentodigital dysplasia, which is caused by Cx43 mutation.91 These results suggest the important role of Cx43 in bone development and homeostasis.
Unlike those with global deletion of Cx43 in osteoblasts and osteocytes, mice with conditional deletion of Cx43 in osteoblasts and osteocytes were viable but developed osteopenia. Cx43 haploinsufficiency in osteoblasts (2.3 kb Cola1(I)-Cre; Cx43−/fl) led to normal mice at birth, but these mice developed reduced bone formation and defective osteoblast functions at six months of age.96 This osteopenic phenotype resulted from direct osteocyte loss. Similarly, deletion of Cx43 in mature osteoblasts and osteocytes with the osteocalcin promoter (Oc-Cre; Cx43−/fl) increased osteocyte apoptosis in the cortical shell of lumbar vertebrae.97 TEM images further revealed the features of osteocyte apoptosis, including chromatin condensation, nuclear fragmentation, and even empty lacunae. Moreover, more osteoclasts were observed at the site of apoptotic osteocytes. Interestingly, bone-formation indexes on the periosteal surface were higher in Oc-Cre; Cx43−/fl mice than in their Cx43−/fl control littermates, whereas no difference was observed on the endocortical surface. Consistent with these results, deletion of Cx43 in the osteocytes of Dmp1-Cre; Cx43fl/fl mice resulted in increased osteocyte apoptosis and a higher prevalence of empty lacunae but did not affect bone mass.97 IHC data from bone sections indicated the reduced prevalence of Opg-expressing osteocytes in Dmp1-Cre; Cx43fl/fl mice, but no change in the Rankl-positive osteocyte ratio was detected. Moreover, the loss of viable osteocytes in Dmp1-Cre; Cx43fl/fl mice reduced local sclerostin levels, which further contributed to increased local bone formation. Together, these observations suggest that Cx43 regulates osteocyte apoptosis and target protein expression.
In addition to the osteopenia developed by Cola1(I)-Cre; Cx43−/fl mice, Cx43 deficiency in osteoblasts attenuated the anabolic response to in vivo mechanical loading.98 After being subjected to a three-point bending protocol for two weeks, the loaded tibiae from Cola1(I)-Cre; Cx43−/fl mice showed significantly reduced mineral apposition and bone-formation rates relative to those of control Cx43+/fl mice. Moreover, these Cola1(I)-Cre; Cx43−/fl mice needed ∼40% more force to generate the required endocortical strain. Similar to these defects during mechanical loading, mice with conditional deletion of Cx43 in mature osteoblasts and osteocytes (Oc-Cre; Cx43fl/fl) failed to properly respond to mechanical unloading.99 At baseline, Oc-Cre; Cx43fl/fl mice had an osteopenic phenotype in cortical bone but not in trabecular bone. When both Oc-Cre; Cx43fl/fl and control mice were challenged with three weeks of mechanical unloading via HLU, the significant loss of cortical bone was observed. However, mechanical testing revealed the increased loss of bone strength and rigidity in Oc-Cre; Cx43fl/fl mice compared with control mice after HLU. Moreover, Oc-Cre; Cx43fl/fl mice did not experience HLU-induced bone loss in trabecular bone. Therefore, together, these data indicate that Cx43 deficiency desensitizes bone to the effects of mechanical loading and unloading.
In addition to its role in mechanical stimulation, Cx43 in osteocytes plays a role in hormone stimulation. Even though conditional deletion of Cx43 in osteocytes (Dmp1-Cre; Cx43fl/fl) did not impact animal body weight or BMD, the mutant mice displayed different responses to anabolic PTH treatment.100 Intermittent PTH administration had similar effects in control and Dmp1-Cre; Cx43fl/fl mice, as measured by the increase in bone mineral deposition and enhanced expression of osteoblast-related genes (Alp, Runx2, Oc, and bone sialoprotein). However, collagen fibers in Dmp1-Cre; Cx43fl/fl mice failed to mature after PTH injection. In addition to its role in PTH signaling, Cx43 is involved in the estrogen pathway.101 When an ovariectomized (OVX) mouse model was developed to mimic estrogen deficiency, IHC results suggested that the OVX group has less staining for the Cx43 protein than the sham group. In this study, three types of mice with different genotypes were used: WT mice, Cx43R76W mice (dominant-negative mutant in which only GJ channels were inhibited) and Cx43Δ130–136 mice (dominant-negative mutant in which both GJ channels and hemichannels were compromised). Compared with WT and Cx43R76W mice, Cx43Δ130–136 mice had significantly decreased vertebral trabecular bone mass and increased apoptotic osteocytes. However, the osteoclast surface in trabecular and cortical bone after OVX was increased in WT and Cx43R76W mice but not in Cx43Δ130–136 mice. These observations suggest that Cx43 in GJs and hemichannels may have different roles in regulating osteocyte and osteoclast activities and that intact Cx43-associated channels are essential for protection of the bone against catabolic effects resulting from estrogen deficiency.
Together, these in vivo observations demonstrate that Cx43 is not required for early osteogenesis but plays important roles in regulating anabolic responses in response to hormone treatment and mechanical stimulation in osteoblasts and osteoclasts (Table 6).
Table 6.
Targeted cells | Genotype | Baseline skeletal phenotype | External stimulation | Ref. | |
---|---|---|---|---|---|
Mechanical | Chemical | ||||
Global | |||||
Cx43−/− | Animal die shortly after birth; delayed intramembranous and endochondral ossification during embryogenesis; skeletal abnormalities in clavicles, ribs, vertebrae and limbs. | n/a | n/a | 94 | |
Cx43R76W | n/a | n/a | Increased osteoclast surface after VOX in WT and Cx43R76W mice, but not in Cx43Δ130–136 mice. | 101 | |
Cx43Δ130–136 | n/a | n/a | Cx43Δ130–136 mice had significant decreased vertebral trabecular bone mass and increased apoptotic osteocytes in VOX model, compared with WT and Cx43R76W mice. | 101 | |
Osteoblasts and osteocytes | |||||
Cola1(I) 2.3-Cre; Cx43–/fl | Normal mice at birth; develop reduced bone formation and defective osteoblast functions at six-month; observed osteocyte loss. | Loaded tibia from CKO mice showed significantly lower mineral apposition rate and bone-formation rate; CKO mice needed ∼40% more force to generate the required endocortical strain. | n/a | 96 | |
OC-Cre; Cx43–/fl | Increased osteocyte apoptosis in the cortical shell of lumbar vertebrae; increased endocortical resorption, and periosteal bone formation; higher marrow cavity and total tissue areas measured at the femoral mid-diaphysis. | Failed to properly respond to mechanical unloading. | n/a | 97 | |
OC-Cre; Cx43fl/fl | Osteopenia phenotype in cortical bone, but not in trabecular bone. | Significant bone loss in cortical bone, but not cortical bone, were observed in both CKO mice in HLU experiments; mechanical testing revealed a greater loss of bone strength and rigidity for CKO mice after HLU. | n/a | 99 | |
Osteocytes | |||||
Dmp1-Cre; Cx43fl/fl | Increased osteocyte apoptosis with higher prevalence of empty lacunae, but not affect bone mass; reduced prevalence of Opg-expression osteocytes in CKO mice, but no changes for Rankl-positive osteocyte ratio between groups; Reduced the sclerostin levels locally. | n/a | n/a | 97 | |
Dmp1-Cre; Cx43fl/fl | No difference in animal body weight and bone mineral density. | n/a | CKO mice failed to increase maturity of collagen fibers after PTH injection. | 100 |
Ref. references, n/a not available, OC osteocalcin, CKO conditional knockout, HLU hindlimb unloading
In addition to in vivo studies, in vitro studies have revealed the detailed molecular contribution of Cx43 to osteocyte mechanotransduction (Fig. 6c). As observed in vivo, the major GJ protein expressed in MLO-Y4 cells is Cx43, and ~5% of total Cx43 is phosphorylated.102Cx43-silenced MLO-Y4 cells underwent spontaneous cell death through the AKT/P27/Caspase-3 pathway.95 Furthermore, fluid stress stimuli regulated Cx43 protein expression and subcellular distribution in MLO-Y4 cells.102–104 Both pulsating and steady fluid flow shear stress over MLO-Y4 cells redistributed the Cx43 protein from the perinuclear region (<2 μm around nuclei) into the cytoplasm and dendritic processes (>2 μm away from nuclei), which was associated with increased intercellular coupling.102 Cx43 protein expression was elevated 30 min after the application of stress but decreased at 24 h after stress. In a similar study, MLO-Y4 cells were exposed to 1 h of oscillating fluid flow, which increased the phosphoserine content of Cx43 by approximately twofold compared with that in cells without flow treatment.104 Moreover, oscillating fluid flow promoted the formation of new GJs between MLOY-4 cells without affecting dye transfer between established GJs, which was dependent on the ERK1/2-MAP kinase pathway.104
In addition to Cx43-mediated GJs, osteocytes use Cx43-dependent hemichannels in response to extracellular stimuli (Fig. 6b). When MLO-Y4 cells were plated at a low density in culture, Cx43 formed hemichannels instead of cell-cell contact GJs in individual cells.105 When these cells were subjected to fluid flow, the hemichannels of cells plated at a lower density released more PGE2 than those of cells plated at a higher density. Inhibitors of other channels, such as the purinergic receptor P2X7 and the prostaglandin transporter PGT, had no effect on PGE2 release. These data suggest that hemichannels regulate PGE2 release in osteocyte mechanotransduction.
Interestingly, Cx43 also participates in osteocyte autocrine effects. Conditioned medium obtained from fluid flow-treated MLO-Y4 cells increased Cx43 protein expression in static cultured MLO-Y4 cells.103 Treatment with purified PGE2 had an effect similar to that of fluid flow induction, suggesting that PGE2 is an autocrine effector responsible for Cx43 expression. When PGE2 was depleted from the fluid flow conditioned medium, the stimulatory effect on GJs was partially but significantly decreased. These data suggest that Cx43 can regulate osteocyte autocrine effects under conditions of mechanical stimulation and that released PGE2 further enhances osteocyte Cx43 expression in a positive feedback loop, eventually resulting in broader and more intense responses.
The function of Cx43 in osteocyte mechanobiology seems to be related to FAs, especially Integrins. MLO-Y4 cells cultured on a soft substrate expressed less Cx43, Vinculin, Paxillin, and Fibronectin than cells cultured on a stiff substrate.106 Immunoprecipitation (IP) results suggested a protein–protein interaction between Cx43 and Paxillin. Moreover, Cx43 was shown to colocalize with Integrins α5β1 in both MLO-Y4 cells and primary osteocytes through IF and IP experiments.107 Following chemical and mechanical activation of Integrins, MLO-Y4 cells were more permissive to dye diffusion via GJs. However, following siRNA-mediated knockdown of Integrin α5 expression, the cells were less permissive to the dye. The same research group further showed that Integrins α5β1 directly interact with Cx43 through their C-termini, which promoted Cx43-mediated GJs and hemichannel opening in response to shear stress.108 This process is partially dependent on the PI3K pathway.108 Moreover, locally applied pN-level force-induced electrical coupling between MLO-Y4 cells required the release of ATP by the stimulated cells, and the junctional conductance increases with the number of junctional connections between cells.59
In addition to Integrins, GJIC and the activity of hemichannels, which are mediated through Cx43, are closely regulated by other cellular components.109 A number of Cx43-interacting proteins, including regulatory protein phosphatases and protein kinases (c-Src is the best studied), structural proteins (notably zona occludens-1/ZO-1, ZO-2, N-cadherins, Vinculin, etc.), and cytoskeletal proteins (MTs and actin), have been recently reported.110,111 These GJ-interacting proteins link Cx43-mediated channels to other subcellular functional compartments and may facilitate the additional roles of Cx43 in transcriptional and cytoskeletal regulation.
In summary, Cx43-mediated GJs and hemichannels play a crucial role in regulating bone homeostasis, especially in responses to hormone and mechanical stimulation.112 First, Cx43-mediated GJs can conduct chemical and mechanical signals among bone cells that translate both anabolic and catabolic responses from osteocytes into bone remodeling. Second, Cx43-mediated hemichannels contribute to autocrine or even endocrine effects. Third, Cx43 directly regulates osteocyte apoptosis, which further influences local osteoblast and osteoclast activity. Finally, Cx43 is in direct and indirect contact with FAs, structural proteins and protein kinases in osteocytes, which further facilitates bone homeostasis.
Ion channels
During cell mechanotransduction, the earliest event that takes place within 1 min of mechanical stimulation is an increase in the intracellular Ca2+ concentration in cells.113 In cultured bone cells, including osteocytes, osteoblasts and osteoclasts, with the results of both patch-clamp recording and calcium-sensitive fluorescent dye detection showed fast and mechanically stimulated calcium flux.114,115 This calcium mobilization process is first triggered by the activation of mechanical-sensitive ion channels (MSICs),114 which are opened by membrane tension changes from plasma membrane disruption under loading116 (Fig. 7). Ex vivo mechanical loading experiments showed that the blockade of MSICs, which are mainly stretch/strain-sensitive cation channels, with GdCl abolished PGI2 and NO production in osteocytes.117
Among all the MSICs, Piezo1 is a promising mechanogating ion channel for osteocyte mechanobiology. Discovery of the molecular structure of Piezo1 showed that Piezo1 is a large ion channel with a special and highly curved blade-like shape118,119 (Figs. 1 and 7). This curved channel is highly engaged with the cell membrane, amplifying the sensitivity of Piezo1 to changes in membrane tension.119 Moreover, Piezo1 is expressed in osteoblasts and osteocytes and regulates mechanical load-dependent bone formation.120,121 Conditional deletion of Piezo1 in osteoblasts and osteocytes with either Oc-Cre or Dmp1-Cre transgenic mice resulted in significantly reduced bone mass and impaired bone structure and bone strength.120–122 In vivo studies further showed that osteoblastic Piezo1-deficient mice were resistant to HLU-induced bone loss122 and that the loss of Piezo1 in osteocytes compromised skeletal responses to mechanical loads.123 However, WT mice administered a Piezo1 agonist showed significantly increased bone mass, mimicking the mechanical loading effect.120 Furthermore, examination of human bone samples showed a negative correlation between PIEZO1 expression and osteoporosis levels.121 In addition, in vitro cell culture studies suggested that Piezo1 regulates osteocyte mechanobiology through several different pathways, including the Akt–Sost pathway124 and YAP/TAZ–Wnt pathway,120 and regulates intracellular calcium signals124 (Fig. 7).
Upon MSIC opening, ions, especially cations, are exchanged between the cytoplasmic and extracellular environments. This process further changes the plasma membrane charge balance and induces the opening of voltage-sensitive calcium channels (VSCs).125 In osteocytes, T- and L-type VSCs are coexpressed and both contribute to mechanically induced calcium flux. For example, in osteocyte-like MLO-Y4 cells, both T- and L-type VSCs are expressed and accelerate ATP release and Erk1/2 activation.126,127 Moreover, during in vivo ulna loading, blockade of L-type VSCs with a specific antagonist (nifedipine or verapamil) in loading rats before experiments reduced loading-induced bone formation by 50%–60%.113 With the sequential opening of MSICs and VSCs, calcium flux takes place in mechanically activated osteocytes.
Interestingly, the calcium that undergoes flux induced by mechanical stimulation is derived from not only external fluid and the medium but also stored internal calcium, such as that in the endoplasmic reticulum (ER). On the one hand, when cells were cultured in medium lacking calcium, bone cells lost the ability to activate calcium flux upon fluid flow.128 On the other hand, blockade of ion channels with inhibitors in both cell culture and animal models only partially inhibited flow responses.114,129 In addition, cultured cells treated with thapsigargin (a drug that depletes intracellular calcium stores) significantly reduced the occurrence of calcium peaks in response to fluid flow.128 These observations suggest that calcium release from intracellular stores (such as the ER) also participates in the calcium response to flow.
These results further show that calcium mobilization in osteocytes is a quantitative response to mechanical loading. Ex vivo loading experiments revealed that the ratio of responding osteocytes was controlled by the loading frequency and magnitude, but the Ca2+ intensity within each osteocyte remained consistent during the response.130 Moreover, this calcium mobilization activated expression of the downstream signal molecules Erk1/2, PGE2, PAK, and osteopontin115 (Fig. 7). Moreover, calcium mobilization also regulated ATP release in osteocytes upon mechanical stimulation. In rat ulnar loading experiments, pretreatment with two L-type VSC antagonists (nifedipine and verapamil) reduced load-induced bone formation and ATP signaling.113 Taken together, these results show that MSICs and VSCs actively participate in osteocyte mechanotransduction. Calcium, the release of which is a very early event in osteocyte mechanotransduction, serves as a powerful second messenger, providing essential information for mechanical responses and participating in downstream regulation.
ECMs: glycocalyx
The primary ECM components in bone are organic collagen and inorganic hydroxyapatite.131 Among these components, the collagen network contributes to the toughness of bone and its resilience to fracture but has little effect on the stiffness of bone.132 During osteocyte maturation, interaction between collagen networks, osteoblast orientation and the lacunae structure has been reported.133 The results of a detailed examination of equine, ovine, and murine bones suggested that osteoblasts are aligned with the highly oriented collagen matrix.133 Moreover, newly synthesized collagen matrix from osteoblasts adopts a preferential orientation in the direction of the cell.134 As a result of the interaction between the matrix and osteogenic differentiation, osteocytes are embedded in a well-polarized environment.135 Moreover, during development, tension, compression, and shear forces from animal activities over time define the main axes of osteocytes and osteocyte lacunae, which are highly oriented along the force direction.131,136 These observations suggest interactive communication between the ECM environment and osteocytes during development, especially during mechanical stimulation.
Even though osteocytes are embedded in the LCS, which allows fluid flow and nutrient exchange for these cells, the space between the LCS wall and the osteocyte plasma membrane is not empty. As discussed, and as presented in Fig. 1, high-resolution TEM and SEM studies revealed PCM and collagen hillocks between the osteocyte cell body and lacunae and between cell processes and canaliculi. In these spaces, together, the ECM components proteoglycans, glycoproteins, and hyaluronic acid form a mesh of PCM, called the glycocalyx.137 The glycocalyx is required to link the osteocyte membrane to LCS walls and serves to sense and transduce mechanical signals from the ECM or fluid flow to osteocytes.137
The large, monomeric heparan sulfate proteoglycan protein Perlecan/Shpg2 has been reported to be a suitable candidate for the functions listed above.138 First, IF and immunogold detection of Perlecan revealed its localization in the pericellular space of the osteocyte LCS in cortical bone.139 Second, atomic force microscopy examination of purified full-length human PERLECAN showed that this protein has an end-to-end length of 170 ± 20 nm and a diameter of 2–4 nm, allowing it to function as a tethering element that connects the osteocyte cell body to the bone matrix.140 Moreover, the Perlecan protein is strong but elastic (elastic constant of 890 pN, Young’s modulus of 71 MPa), which allows the protein to withstand any drag forces from physiological fluid flow.140 Third, Perlecan is essential for the integrity of the osteocyte LCS.139 Global deletion of Perlecan in mice resulted in reductions in the total canalicular area, canalicular density and number of transverse tethering elements in the canaliculus.79 Fourth, Perlecan-deficient mice exhibited higher solute transport and higher shear stress in the bone.141 Fifth, when these mice were subjected to mechanical tibial loading, loading-induced anabolic bone formation was abolished, but this was not observed in control mice.141 Real-time calcium recording further showed that Perlecan-deficient mice experienced decreases in the overall Ca2+ response rate, calcium peaks, peak magnitude, and recovery speed to baseline.142
In summary, ECM components, especially the glycocalyx in the pericellular space, actively contribute to osteocyte mechanotransduction. These glycocalyx molecules act as a tether or ligand for osteocyte membrane receptors, conveying mechanical signals due to either ECM deformation or fluid shear to the osteocyte surface. All of these important functions make the glycocalyx in the ECM an essential osteocyte mechanosensor during force adaptation.
Signaling pathways that regulate osteocyte mechanobiology
During skeletal development, multiple classical signaling pathways have been shown to play indispensable roles in bone formation through both genetic modification of experimental animals and human genomic studies. These classical pathways include the Notch, Hedgehog, Bmp, and FGFR signaling pathways.143 These pathways exhibit some common features. Receptors on the plasma membrane are activated through direct binding to specific ligands, leading to the activation of sequential signaling cascades and expression of downstream target genes.144–147 All of these pathways are involved in the regulation of bone-formation processes, such as osteoblast differentiation and mineralization and limb patterning. Interestingly, Notch signaling has dual effects on osteogenesis and osteoclastogenesis.148 On the one hand, Notch enhances osteoblast mineralization, osteogenic differentiation and thereby bone formation; on the other hand, Notch also facilitates bone resorption. In addition to traditional pathways in bone development, several classical and new pathways that regulate bone homeostasis during osteocyte mechanotransduction have emerged (Fig. 8).
Wnt/β-Catenin
The Wnt signaling pathway, the major regulator of the transition of stem cells into mature osteoblasts, has been proven to be a key regulator of bone mass. Mutations of WNT1 in humans cause early-onset osteoporosis and osteogenesis imperfecta.149,150 A comprehensive study of transgenic mice carrying mutations in the Wnt pathway showed the association between experimental phenotypes and clinical observations in human bone.151
Mechanistically, the canonical Wnt/β-Catenin pathway is activated through the binding of Wnt ligands to a coreceptor complex (Fig. 8) consisting of Lrp5 or Lrp6 and the frizzled family member FZD.152,153 This binding further activates the intercellular effector Dishevelled (Dsh) by FZD-mediated phosphorylation. Dsh activation leads to the phosphorylation of Glycogen Synthase Kinase-3β (Gsk-3β), which inhibits free β-Catenin in the cytosol by phosphorylating β-Catenin at multiple serine/threonine sites. Once GSK-3β is phosphorylated by Dsh, it releases captured β-Catenin. As a result, free β-catenin is translocated to nuclei, where it binds its coeffectors Tcf and Lef, inducing downstream gene transcription. In addition to its functions in bone development, the Wnt pathway is an important osteocyte mechanotransduction pathway. For example, during cyclic compression loading in WT mice, significant expression of the Wnt pathway-related genes encoding Wnt10B, SFRP1, Cyclin D1, FzD2, WISP2, and Cx43 was induced.154
As a major receptor in the Wnt pathway, Lrp5 has been shown to be highly important in osteocyte mechanotransduction. In humans, loss-of-function mutations in LRP5 are tightly associated with osteoporosis–pseudoglioma syndrome, which is characterized by low BMD and skeletal fragility,155 and gain-of-function mutations in LRP5 lead to a high bone mass phenotype.156 Experimental transgenic Lrp5-null (Lrp5−/−) mice had significantly reduced bone mass and strength compared with those in control mice.157 However, mice expressing constitutively activated mutant Lrp5 (Lrp5G171V) displayed a high bone mass phenotype with stronger mechanical properties, even those with a heterozygous background.158 When challenged with cyclic mechanical loading or disuse-associated mechanical unloading, Lrp5-null mice showed reduced osteogenic responses after loading157,159 and a greater loss of cancellous bone after disuse.159
The Wnt effector β-Catenin is also involved in osteocyte mechanical responses. Deletion of β-Catenin in osteocytes (Dmp1-Cre; β-Catfl/fl) resulted in reduced skeletal mass.160 This low bone mass phenotype seemed to be related to an increased osteoclast number, but normal osteoblast function and osteocyte density were observed.161 In these mice, the anabolic effects of mechanical force loading were compromised.160 Moreover, β-Catenin may influence osteocyte mechanotransduction in a dose- and sex-related manner. Studies using heterozygous mice in which one copy of β-Catenin was deleted (Dmp1-Cre; β-Catfl/+) showed opposite results. Bonewald et al. found that 5-month-old male, but not female, mice had significantly a reduced trabecular bone volume compared with that of control mice.162 However, Johnson et al. found that female, but not male, heterozygous mice showed a reduced trabecular bone volume and increased trabecular bone separation compared with those in their sex-matched controls.163 When these heterozygous mice were subjected to HLU experiments, female, but not male, mice displayed greater trabecular bone loss than controls.162 When these heterozygous mice were subjected to external loading experiments, neither male nor female heterozygous mice exhibited a significant increase in new cortical bone formation.163
Together, these data suggest that mechanical stimulation activates the canonical Wnt/β-catenin pathway and thereby influences osteocyte activity in load-induced bone formation. The downstream effects of β-Catenin include the expression of Wnt target genes154 and secretory proteins (Opg, Osteopontin),157,161 as well as load-induced PGE2 secretion.164
FAs
Sensing of the external environment and stimulation by osteocytes is largely dependent on the connects between cells and the ECM–Integrin-based FAs. As discussed above (Fig. 3 and Table 5), Integrins, especially Integrin β subunits, are essential for bone development and osteocyte mechanotransduction. Interestingly, Integrins act not only as a physical connector of cells and ECM but also as a signal center for both “outside-in” and “inside-out” FA signaling.23,82,165 For “outside-in” signals, Integrins transmit external signals, including chemical and physical signals, into the cell and provide information regarding cellular location, microenvironment, and adhesive state. These signals activate internal signaling pathways that determine cell migration, survival and differentiation. In addition, “inside-out” signals from the cytoplasmic tails of Integrins influence the conformational changes of their extracellular domains and further regulate the affinity for extracellular ligands. With this bidirectional transmission between the intracellular environment and intercellular status, Integrins carry out dynamic, spatial, and temporal regulation in osteocytes (Fig. 8).
From a large literature study, an “Integrin adhesome” composing a network of 156 proteins was proposed to be associated with FAs.166 In addition to Integrin subunits, several FA-associated proteins have been proven to have essential roles in regulating bone development (Fig. 4). For example, Kindlin-2, a direct β1 Integrin- and β3 Integrin-binding protein, is essential for both bone development and osteocyte functions.167,168 Deletion of Kindlin-2 in limb MSCs with Prx1-Cre caused neonatal lethality, chondrodysplasia, and loss of the skull vault by inhibiting Sox9 expression and TGF-β signaling.167 Conditional deletion of Kindlin-2 in osteocytes using a 10-kb Dmp1-Cre transgene greatly altered the bone microenvironment and bone remodeling, resulting in a severe osteopenic phenotype.168 The results from this study demonstrated that Kindlin-2 controls the expression of sclerostin and Rankl in osteocytes and thereby bone remodeling. Another FA-binding protein, Pinch, is also involved in osteogenesis and osteocyte mechanosensation. Global Pinch2 deletion and conditional Pinch1 deletion in osteocytes resulted in significant bone loss in mice, whereas single deletion of one isoform of Pinch did not cause any marked skeletal phenotypes.169 The loss of both Pinch isoforms in osteocytes caused apoptotic death in cortical osteocytes with enhanced sclerostin detection in bone sections.170 Moreover, mice in which both Pinch isoforms were deleted from osteocytes showed reduced anabolic bone formation under mechanical loading conditions.169 Moreover, deletion of the FA signaling protein FA kinase in Osx-expressing cells also caused a low bone mass phenotype, resulting from compromised osteogenic differentiation.171
Taken together, these results show that the Integrin-centered FA signaling pathway is essential for skeletogenesis and tightly associated with bone mechanobiology. More studies focused on individual components of the adhesome are required, and osteocyte mechanobiology should be studied in more detail.
Apoptosis and senescence
Osteocyte apoptosis, a form of programmed cell death, and senescence, a death-resistance cell fate program, are common features of aging bone tissue (Fig. 8). Both in vitro and in vivo studies have shown that appropriate mechanical stimulation prevents osteocyte apoptosis. The results from in vitro culture studies further suggested that mechanical stimulation induces Erk activation through Integrin and the cytoskeleton in osteocytes and supports osteocyte survival.172 However, damage-inducing loading induced osteocyte apoptosis,173 which is similar to the effects of disuse.174 In microcracks generated in overloading experiments, osteocyte apoptosis was found to occur adjacent to microdamage, accompanied by high Bax expression and TUNEL signaling.175 These apoptotic osteocytes further induced Rankl expression and osteoclastogenesis, which resulted in increased bone resorption and bone mass loss.176 Interestingly, in experimental animals, treatment with an apoptosis inhibitor (the pancaspase inhibitor Q-VD-OPh) rescued osteocyte cell loss and bone mass reduction during HLU and fatigue loading experiments.173,174
Compared with osteocyte apoptosis, less is known about senescence. Both apoptosis and senescence appear to be tightly associated with age-related bone loss through two independent pathways.177 Senescence is a cell fate program during which death-resistant cells respond to DNA damage to prevent the replication of DNA mutations. Senescent cells can release various cytokines, known as the proinflammatory secretome or senescence-associated secretory phenotype, causing significant damage to the surrounding tissues.178 Studies focused on endurance and resistance exercises suggested the beneficial effect of exercise on osteocyte viability, potentially through preserved mitochondrial function and the inhibition of osteocyte senescence.177 More evidence to illustrate the relationship between mechanical stimulation and osteocyte senescence is required and could provide useful insights into antiresorptive therapy by reduced osteocyte senescence and osteocyte apoptosis.179
Other mechano-related pathways
Sclerostin
Sclerostin, an antagonist of Wnt//β-Catenin signaling, is widely known as an inhibitor of bone formation. In osteocytes, sclerostin is detected in the cell body as well as cell processes.180 Sclerostin antagonizes Wnt signaling through its competitive binding to Lrp5 and Lrp6 at their first two YWTD-EGF repeat domains.181 This binding disrupts Wnt-induced Frizzled-LRP complex formation and thus influences activation of the downstream effector β-Catenin182 (Fig. 8). In humans, genetic mutations in the SOST gene, which encodes SCLEROSTIN, cause sclerosteosis, an autosomal recessive disease characterized by high bone mass and bone tissue overgrowth.183 Similar to the results of human genetic studies, Sost deletion in mice resulted in a high bone mass throughout life, and these mice exhibited fewer apoptotic osteocytes and apoptotic osteoblasts in their bone tissue with enhanced Wnt//β-Catenin signaling.184
Most importantly, Sclerostin is involved in osteocyte mechanotransduction through its antagonistic effects on the Wnt//β-Catenin pathway and potentially other pathways. In WT mice, mechanical ulna loading reduced the level of Sost transcription, while HLU increased Sclerostin expression.25 These data are consistent with the increased circulating SCLEROSTIN level observed in humans during prolonged bed rest and immobilization.43Sost-null mice failed to sense unloading and displayed resistance to any bone loss.184 In addition to the antagonistic effects of Sclerostin on Wnt//β-Catenin signaling, in vitro culture experiments suggest that Sclerostin is involved in osteocyte Rankl and Opg expression,43 calcium flux,53 and oxygen sensing185 during FSS induction. Together, these data demonstrate that Sclerostin participates in osteocyte mechanobiology through Wnt signaling and potentially other pathways.
YAP/TAZ
Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ, also known as WWTR1) are two proto-oncogene proteins that are widely known as mechanosensors and mechanotransducers in various cell types.186 A pioneering work by Dupont et al. demonstrated YAP/TAZ translocation from the cytoplasm to the nucleus in MSC differentiation, a process that is decided by ECM stiffness and physical constraints.187 Moreover, in this process, YAP/TAZ acted as sensors and mediators of mechanical cues, coordinated with signals from Rho GTPase and tension of the actomyosin cytoskeleton, and finally contributed to cell differentiation187 (Fig. 8). Importantly, YAP/TAZ could respond to a complex physical microenvironment and mechanical cues, ranging from ECM properties, cell geometry, cell density, and cell polarity to shear stress.188 The overall consequences of YAP/TAZ activity during cellular mechanobiology include organogenesis, tissue homeostasis and multiple diseases, such as fibrosis, pulmonary hypertension, inflammation, muscular dystrophy, and cancer.188,189
In skeletal tissue, YAP/TAZ have been detected throughout osteolineage cell differentiation.190 In MSCs, mechanical niches trigger YAP/TAZ nuclear translocation, contributing to osteoblastogenesis and bone formation.191 In skeletal-lineage cells, deletion of YAP/TAZ using Osx-Cre caused an osteogenesis imperfecta-like phenotype, the severity of which was dependent on allele dose.192 Interestingly, a greater osteopenia phenotype was observed with homozygous TAZ deletion than with homozygous YAP deletion.192 In experimental animals, YAP/TAZ deletion reduced bone mass and bone material properties, which was associated with impaired collagen content and organization. In mature osteoblasts and osteocytes, YAP/TAZ increased osteoblast number and accelerated bone formation. Osteocyte-specific deletion of YAP/TAZ with Dmp1-Cre resulted in low bone mass, impaired bone mechanical properties, and disorganized collagen fibers.193 Furthermore, YAP/TAZ deletion in osteocytes reduced expression of the matrix proteases Mmp13, Mmp14 and Ctsk, which resulted in reduced canalicular network density, length and branching.193 Together, these data suggest the important role of YAP/TAZ in osteogenesis and bone formation. Great effort is needed to determine the mechanism(s) of nuclear YAP/TAZ translocation during the mechanical stimulation of osteocytes.
Conclusions and perspectives
With rapidly increasing attention on osteocyte mechanobiology, increasingly more players in mechanosensation and mechanotransduction are being discovered. A better understanding of the details of osteocyte mechanobiology will provide promising treatments for disease-, disuse-, and age-related bone loss. These treatments could be science-based advice regarding daily activities, noninvasive machine-based mechanical stimulation, or simply small molecules or peptides that regulate important players in osteocyte mechanobiology. One exciting example is the approval of romosozumab, a Sclerostin monoclonal antibody drug, for the clinical treatment of osteogenesis imperfecta and low BMD in postmenopausal women and patients with a high risk of fracture.194
The importance of osteocyte mechanobiology is related to not only bone health but also the homeostasis of other organs. On the one hand, as important endocrine cells, osteocytes can regulate the functions of multiple organs, such as muscle growth, memory in the brain, and fertility in the testis.7 Meanwhile, mechanical stimulation enhances and regulates osteocyte secretion activity.1,4,6,10 As a result, osteocyte mechanobiology participates in several different pathological conditions, such as OA,195 inflammation,196,197 bone metastases,198,199 and aging.200,201 For instance, unbalanced chronic overloading on one side of OA joints results in continuous thinning of the cartilage, bone attrition, and sclerosis.202 Osteocytes derived from OA patients have a rounded morphology with reduced Integrin β3 expression.195,203 Moreover, decellularized matrices from OA patients showed abnormal matrix components195 and increased stiffness.204 On the other hand, bone tissue is also a target for other organs. For example, adipocyte-specific Kindlin-2 deletion caused a severe lipodystrophy phenotype.205 These transgenic mice had a high bone mass phenotype, which could have been the result of reduced leptin production from fat tissue in the animals, affecting bone metabolism.205,206
These results suggest interorgan communication between bone and distal organs, which indicates that the mechanotransductive properties and abilities of osteocytes can influence multiple cell types from different organs, including the surrounding bone cells and distal cells. Moreover, changes in possible ECM components and the morphology of osteocytes due to the influence of other organs can also affect osteocyte mechanobiology. Therefore, osteocytes residing in bone and other cells from various organs form a continuous loop that regulates whole-body homeostasis.
From the perspective of osteocytes, how these cells coordinate different mechanosensors and pathways in a complex stimulating environment, such as during daily physical activities, such as running, walking, and jogging, remains intriguing. Complex stimulation triggers more than one mechanosensor and activates more than one pathway, necessitating interactions between different players in the process. Therefore, considering osteocyte mechanobiology in a systematic way is a future direction for both basic research and potential clinical utilization. Moreover, osteocytes are not the only mechanosensitive cells in bone. In addition to these terminally differentiated cells, at least three different bone cell types, i.e., bone-resorbing osteoclasts, bone-forming osteoblasts, and osteoprogenitors, show the ability to sense and respond to biophysical signals.18 It is important to dissect these different cell types, different force origins, and the properties of different types of stimulation in the process to speculate on the difference between the responses of various cell types to complex physical stimuli and understand the possible universal roles of bone mechanobiology.
Acknowledgements
The authors acknowledge the assistance of the Core Research Facilities of the Southern University of Science and Technology. This work was supported, in part, by grants from the National Key Research and Development Program of China (2019YFA0906004 and 2019YFA0906001), the National Natural Science Foundation of China (81991513, 8163066, 81870532, and 81972100), the Guangdong Provincial Science and Technology Innovation Council (2017B030301018), the Science and Technology Innovation Commission of Shenzhen Municipal Government (JCYJ20180302174117738, JCYJ20180302174246105, KQJSCX20180319114434843, and JSGG20180503182321166), and the China Postdoctoral Science Foundation (2019M651641).
Competing interests
The authors declare no competing interests.
Contributor Information
Huiling Cao, Email: caohl@sustech.edu.cn.
Guozhi Xiao, Email: xiaogz@sustech.edu.cn.
References
- 1.Bonewald LF. The amazing osteocyte. J. Bone Min. Res. 2011;26:229–238. doi: 10.1002/jbmr.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 2000;21:115–137. doi: 10.1210/edrv.21.2.0395. [DOI] [PubMed] [Google Scholar]
- 3.Schaffler MB, Kennedy OD. Osteocyte signaling in bone. Curr. Osteoporos. Rep. 2012;10:118–125. doi: 10.1007/s11914-012-0105-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Schaffler MB, Cheung WY, Majeska R, Kennedy O. Osteocytes: master orchestrators of bone. Calcif. Tissue Int. 2014;94:5–24. doi: 10.1007/s00223-013-9790-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simoes MJ, Cerri PS. Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed. Res. Int. 2015;2015:421746. doi: 10.1155/2015/421746. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Dallas SL, Prideaux M, Bonewald LF. The osteocyte: an endocrine cell… and more. Endocr. Rev. 2013;34:658–690. doi: 10.1210/er.2012-1026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Han Y, You X, Xing W, Zhang Z, Zou W. Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts. Bone Res. 2018;6:16. doi: 10.1038/s41413-018-0019-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Bonewald LF, Wacker MJ. FGF23 production by osteocytes. Pediatr. Nephrol. 2013;28:563–568. doi: 10.1007/s00467-012-2309-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Rochefort GY, Pallu S, Benhamou CL. Osteocyte: the unrecognized side of bone tissue. Osteoporos. Int. 2010;21:1457–1469. doi: 10.1007/s00198-010-1194-5. [DOI] [PubMed] [Google Scholar]
- 10.Uda Y, Azab E, Sun N, Shi C, Pajevic PD. Osteocyte mechanobiology. Curr. Osteoporos. Rep. 2017;15:318–325. doi: 10.1007/s11914-017-0373-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Yavropoulou MP, Yovos JG. The molecular basis of bone mechanotransduction. J. Musculoskelet. Neuronal Interact. 2016;16:221–236. [PMC free article] [PubMed] [Google Scholar]
- 12.Wang JH, Thampatty BP. An introductory review of cell mechanobiology. Biomech. Model Mechanobiol. 2006;5:1–16. doi: 10.1007/s10237-005-0012-z. [DOI] [PubMed] [Google Scholar]
- 13.Wolfenson H, Yang B, Sheetz MP. Steps in mechanotransduction pathways that control cell morphology. Annu Rev. Physiol. 2019;81:585–605. doi: 10.1146/annurev-physiol-021317-121245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Wolff, J. Das Gesetz der Transformation der Knochen. (Berlin, A. Hirschwald, 1892).
- 15.Frost HM. Bone “mass” and the “mechanostat”: a proposal. Anat. Rec. 1987;219:1–9. doi: 10.1002/ar.1092190104. [DOI] [PubMed] [Google Scholar]
- 16.Jacobs CR, Temiyasathit S, Castillo AB. Osteocyte mechanobiology and pericellular mechanics. Annu Rev. Biomed. Eng. 2010;12:369–400. doi: 10.1146/annurev-bioeng-070909-105302. [DOI] [PubMed] [Google Scholar]
- 17.Tatsumi S, et al. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 2007;5:464–475. doi: 10.1016/j.cmet.2007.05.001. [DOI] [PubMed] [Google Scholar]
- 18.Thompson WR, Rubin CT, Rubin J. Mechanical regulation of signaling pathways in bone. Gene. 2012;503:179–193. doi: 10.1016/j.gene.2012.04.076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Wassermann F, Yaeger JA. Fine structure of the osteocyte capsule and of the wall of the lacunae in bone. Z. für Zellforsch. und Mikroskopische Anat. 1965;67:636–652. doi: 10.1007/BF00340329. [DOI] [Google Scholar]
- 20.McNamara LM, Majeska RJ, Weinbaum S, Friedrich V, Schaffler MB. Attachment of osteocyte cell processes to the bone matrix. Anat. Rec. 2009;292:355–363. doi: 10.1002/ar.20869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Sharma D, et al. Alterations in the osteocyte lacunar-canalicular microenvironment due to estrogen deficiency. Bone. 2012;51:488–497. doi: 10.1016/j.bone.2012.05.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Wang Y, McNamara LM, Schaffler MB, Weinbaum S. A model for the role of integrins in flow induced mechanotransduction in osteocytes. Proc. Natl Acad. Sci. USA. 2007;104:15941–15946. doi: 10.1073/pnas.0707246104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Geoghegan IP, Hoey DA, McNamara LM. Integrins in osteocyte biology and mechanotransduction. Curr. Osteoporos. Rep. 2019;17:195–206. doi: 10.1007/s11914-019-00520-2. [DOI] [PubMed] [Google Scholar]
- 24.Kalajzic I, et al. In vitro and in vivo approaches to study osteocyte biology. Bone. 2013;54:296–306. doi: 10.1016/j.bone.2012.09.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Robling AG, et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J. Biol. Chem. 2008;283:5866–5875. doi: 10.1074/jbc.M705092200. [DOI] [PubMed] [Google Scholar]
- 26.Rubin C, Xu G, Judex S. The anabolic activity of bone tissue, suppressed by disuse, is normalized by brief exposure to extremely low-magnitude mechanical stimuli. FASEB J. 2001;15:2225–2229. doi: 10.1096/fj.01-0166com. [DOI] [PubMed] [Google Scholar]
- 27.De Souza RL, et al. Non-invasive axial loading of mouse tibiae increases cortical bone formation and modifies trabecular organization: a new model to study cortical and cancellous compartments in a single loaded element. Bone. 2005;37:810–818. doi: 10.1016/j.bone.2005.07.022. [DOI] [PubMed] [Google Scholar]
- 28.Spatz JM, et al. Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading. J. Bone Min. Res. 2013;28:865–874. doi: 10.1002/jbmr.1807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Robling AG, Hinant FM, Burr DB, Turner CH. Improved bone structure and strength after long-term mechanical loading is greatest if loading is separated into short bouts. J. Bone Min. Res. 2002;17:1545–1554. doi: 10.1359/jbmr.2002.17.8.1545. [DOI] [PubMed] [Google Scholar]
- 30.Tu X, et al. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. Bone. 2012;50:209–217. doi: 10.1016/j.bone.2011.10.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Ko FC, et al. In vivo cyclic compression causes cartilage degeneration and subchondral bone changes in mouse tibiae. Arthritis Rheum. 2013;65:1569–1578. doi: 10.1002/art.37906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Lynch ME, et al. Tibial compression is anabolic in the adult mouse skeleton despite reduced responsiveness with aging. Bone. 2011;49:439–446. doi: 10.1016/j.bone.2011.05.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Lee KC, Maxwell A, Lanyon LE. Validation of a technique for studying functional adaptation of the mouse ulna in response to mechanical loading. Bone. 2002;31:407–412. doi: 10.1016/S8756-3282(02)00842-6. [DOI] [PubMed] [Google Scholar]
- 34.Fritton JC, Myers ER, Wright TM, van der Meulen MC. Loading induces site-specific increases in mineral content assessed by microcomputed tomography of the mouse tibia. Bone. 2005;36:1030–1038. doi: 10.1016/j.bone.2005.02.013. [DOI] [PubMed] [Google Scholar]
- 35.Lynch ME, et al. Cancellous bone adaptation to tibial compression is not sex dependent in growing mice. J. Appl Physiol. 2010;109:685–691. doi: 10.1152/japplphysiol.00210.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Jackson JR, et al. Satellite cell depletion does not inhibit adult skeletal muscle regrowth following unloading-induced atrophy. Am. J. Physiol. Cell Physiol. 2012;303:C854–C861. doi: 10.1152/ajpcell.00207.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Tidball JG, Wehling-Henricks M. Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo. J. Physiol. 2007;578:327–336. doi: 10.1113/jphysiol.2006.118265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Brocca L, et al. FoxO-dependent atrogenes vary among catabolic conditions and play a key role in muscle atrophy induced by hindlimb suspension. J. Physiol. 2017;595:1143–1158. doi: 10.1113/JP273097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Ajubi NE, et al. Pulsating fluid flow increases prostaglandin production by cultured chicken osteocytes–a cytoskeleton-dependent process. Biochem Biophys. Res. Commun. 1996;225:62–68. doi: 10.1006/bbrc.1996.1131. [DOI] [PubMed] [Google Scholar]
- 40.Klein-Nulend J, Burger EH, Semeins CM, Raisz LG, Pilbeam CC. Pulsating fluid flow stimulates prostaglandin release and inducible prostaglandin G/H synthase mRNA expression in primary mouse bone cells. J. Bone Min. Res. 1997;12:45–51. doi: 10.1359/jbmr.1997.12.1.45. [DOI] [PubMed] [Google Scholar]
- 41.Sterck JG, Klein-Nulend J, Lips P, Burger EH. Response of normal and osteoporotic human bone cells to mechanical stress in vitro. Am. J. Physiol. 1998;274:E1113–E1120. doi: 10.1152/ajpendo.1998.274.6.E1113. [DOI] [PubMed] [Google Scholar]
- 42.Li J, Rose E, Frances D, Sun Y, You L. Effect of oscillating fluid flow stimulation on osteocyte mRNA expression. J. Biomech. 2012;45:247–251. doi: 10.1016/j.jbiomech.2011.10.037. [DOI] [PubMed] [Google Scholar]
- 43.Spatz JM, et al. The Wnt inhibitor sclerostin is up-regulated by mechanical unloading in osteocytes in vitro. J. Biol. Chem. 2015;290:16744–16758. doi: 10.1074/jbc.M114.628313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Slyfield CR, Tkachenko EV, Wilson DL, Hernandez CJ. Three-dimensional dynamic bone histomorphometry. J. Bone Min. Res. 2012;27:486–495. doi: 10.1002/jbmr.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Morrell AE, et al. Mechanically induced Ca(2+) oscillations in osteocytes release extracellular vesicles and enhance bone formation. Bone Res. 2018;6:6. doi: 10.1038/s41413-018-0007-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Kuttenberger J, Polska E, Schaefer BM. A novel three-dimensional bone chip organ culture. Clin. Oral. Investig. 2013;17:1547–1555. doi: 10.1007/s00784-012-0833-y. [DOI] [PubMed] [Google Scholar]
- 47.Sun Q, et al. Ex vivo 3D osteocyte network construction with primary murine bone cells. Bone Res. 2015;3:15026. doi: 10.1038/boneres.2015.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Michael Sheetz, H. Y. The Cell as a Machine 1 edn, 0–434 (Cambridge university press, 2019).
- 49.Pegoraro, A. F., Janmey, P. & Weitz, D. A. Mechanical Properties of the Cytoskeleton and Cells. Cold Spring Harb. Perspect. Biol9, a022038 (2017). [DOI] [PMC free article] [PubMed]
- 50.Klein-Nulend J, Bacabac RG, Bakker AD. Mechanical loading and how it affects bone cells: the role of the osteocyte cytoskeleton in maintaining our skeleton. Eur. Cell Mater. 2012;24:278–291. doi: 10.22203/eCM.v024a20. [DOI] [PubMed] [Google Scholar]
- 51.Kardas D, Nackenhorst U, Balzani D. Computational model for the cell-mechanical response of the osteocyte cytoskeleton based on self-stabilizing tensegrity structures. Biomech. Modeling Mechanobiol. 2013;12:167–183. doi: 10.1007/s10237-012-0390-y. [DOI] [PubMed] [Google Scholar]
- 52.Tanaka-Kamioka K, Kamioka H, Ris H, Lim SS. Osteocyte shape is dependent on actin filaments and osteocyte processes are unique actin-rich projections. J. Bone Min. Res. 1998;13:1555–1568. doi: 10.1359/jbmr.1998.13.10.1555. [DOI] [PubMed] [Google Scholar]
- 53.Lyons, J. S. et al. Microtubules tune mechanotransduction through NOX2 and TRPV4 to decrease sclerostin abundance in osteocytes. Sci. Signal10, 5748 (2017). [DOI] [PMC free article] [PubMed]
- 54.Moorer MC, Buo AM, Garcia-Pelagio KP, Stains JP, Bloch RJ. Deficiency of the intermediate filament synemin reduces bone mass in vivo. Am. J. Physiol. Cell Physiol. 2016;311:C839–C845. doi: 10.1152/ajpcell.00218.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Zhang K, et al. E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation. Mol. Cell Biol. 2006;26:4539–4552. doi: 10.1128/MCB.02120-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Prideaux M, Loveridge N, Pitsillides AA, Farquharson C. Extracellular matrix mineralization promotes E11/gp38 glycoprotein expression and drives osteocytic differentiation. PLoS ONE. 2012;7:e36786. doi: 10.1371/journal.pone.0036786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Staines KA, et al. Conditional deletion of E11/podoplanin in bone protects against load-induced osteoarthritis. BMC Musculoskelet. Disord. 2019;20:344. doi: 10.1186/s12891-019-2731-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Burra S, et al. Dendritic processes of osteocytes are mechanotransducers that induce the opening of hemichannels. Proc. Natl Acad. Sci. USA. 2010;107:13648–13653. doi: 10.1073/pnas.1009382107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Wu D, Schaffler MB, Weinbaum S, Spray DC. Matrix-dependent adhesion mediates network responses to physiological stimulation of the osteocyte cell process. Proc. Natl Acad. Sci. USA. 2013;110:12096–12101. doi: 10.1073/pnas.1310003110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Thi MM, Suadicani SO, Schaffler MB, Weinbaum S, Spray DC. Mechanosensory responses of osteocytes to physiological forces occur along processes and not cell body and require αVβ3 integrin. Proc. Natl Acad. Sci. USA. 2013;110:21012–21017. doi: 10.1073/pnas.1321210110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Terenzio M, Schiavo G, Fainzilber M. Compartmentalized signaling in neurons: from cell biology to neuroscience. Neuron. 2017;96:667–679. doi: 10.1016/j.neuron.2017.10.015. [DOI] [PubMed] [Google Scholar]
- 62.Davenport JR, Yoder BK. An incredible decade for the primary cilium: a look at a once-forgotten organelle. Am. J. Physiol. Ren. Physiol. 2005;289:F1159–F1169. doi: 10.1152/ajprenal.00118.2005. [DOI] [PubMed] [Google Scholar]
- 63.Temiyasathit S, Jacobs CR. Osteocyte primary cilium and its role in bone mechanotransduction. Ann. N. Y. Acad. Sci. 2010;1192:422–428. doi: 10.1111/j.1749-6632.2009.05243.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Huber C, Cormier-Daire V. Ciliary disorder of the skeleton. Am. J. Med. Genet C. Semin. Med. Genet. 2012;160C:165–174. doi: 10.1002/ajmg.c.31336. [DOI] [PubMed] [Google Scholar]
- 65.Hoey DA, Chen JC, Jacobs CR. The primary cilium as a novel extracellular sensor in bone. Front. Endocrinol. 2012;3:75. doi: 10.3389/fendo.2012.00075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Hoey DA, Tormey S, Ramcharan S, O’Brien FJ, Jacobs CR. Primary cilia-mediated mechanotransduction in human mesenchymal stem cells. Stem Cells. 2012;30:2561–2570. doi: 10.1002/stem.1235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Ascenzi MG, et al. Effect of localization, length and orientation of chondrocytic primary cilium on murine growth plate organization. J. Theor. Biol. 2011;285:147–155. doi: 10.1016/j.jtbi.2011.06.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Xiao Z, et al. Cilia-like structures and polycystin-1 in osteoblasts/osteocytes and associated abnormalities in skeletogenesis and Runx2 expression. J. Biol. Chem. 2006;281:30884–30895. doi: 10.1074/jbc.M604772200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Malone AM, et al. Primary cilia mediate mechanosensing in bone cells by a calcium-independent mechanism. Proc. Natl Acad. Sci. USA. 2007;104:13325–13330. doi: 10.1073/pnas.0700636104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Uzbekov RE, et al. Centrosome fine ultrastructure of the osteocyte mechanosensitive primary cilium. Microsc. Microanal. 2012;18:1430–1441. doi: 10.1017/S1431927612013281. [DOI] [PubMed] [Google Scholar]
- 71.Coughlin TR, Voisin M, Schaffler MB, Niebur GL, McNamara LM. Primary cilia exist in a small fraction of cells in trabecular bone and marrow. Calcif. Tissue Int. 2015;96:65–72. doi: 10.1007/s00223-014-9928-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Kwon RY, Temiyasathit S, Tummala P, Quah CC, Jacobs CR. Primary cilium-dependent mechanosensing is mediated by adenylyl cyclase 6 and cyclic AMP in bone cells. FASEB J. 2010;24:2859–2868. doi: 10.1096/fj.09-148007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Lehti MS, et al. Cilia-related protein SPEF2 regulates osteoblast differentiation. Sci. Rep. 2018;8:859. doi: 10.1038/s41598-018-19204-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Temiyasathit S, et al. Mechanosensing by the primary cilium: deletion of Kif3A reduces bone formation due to loading. PLoS ONE. 2012;7:e33368. doi: 10.1371/journal.pone.0033368. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Qiu N, et al. Disruption of Kif3a in osteoblasts results in defective bone formation and osteopenia. J. Cell Sci. 2012;125:1945–1957. doi: 10.1242/jcs.095893. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Lee KL, et al. Adenylyl cyclase 6 mediates loading-induced bone adaptation in vivo. FASEB J. 2014;28:1157–1165. doi: 10.1096/fj.13-240432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Oliazadeh N, Gorman KF, Eveleigh R, Bourque G, Moreau A. Identification of elongated primary cilia with impaired mechanotransduction in idiopathic scoliosis patients. Sci. Rep. 2017;7:44260. doi: 10.1038/srep44260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Geiger B, Spatz JP, Bershadsky AD. Environmental sensing through focal adhesions. Nat. Rev. Mol. Cell Biol. 2009;10:21–33. doi: 10.1038/nrm2593. [DOI] [PubMed] [Google Scholar]
- 79.Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res. 2010;339:269–280. doi: 10.1007/s00441-009-0834-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Hughes DE, Salter DM, Dedhar S, Simpson R. Integrin expression in human bone. J. Bone Min. Res. 1993;8:527–533. doi: 10.1002/jbmr.5650080503. [DOI] [PubMed] [Google Scholar]
- 81.Duong LT, Lakkakorpi P, Nakamura I, Rodan GA. Integrins and signaling in osteoclast function. Matrix Biol. 2000;19:97–105. doi: 10.1016/S0945-053X(00)00051-2. [DOI] [PubMed] [Google Scholar]
- 82.Marie PJ, Hay E, Saidak Z. Integrin and cadherin signaling in bone: role and potential therapeutic targets. Trends Endocrinol. Metab. 2014;25:567–575. doi: 10.1016/j.tem.2014.06.009. [DOI] [PubMed] [Google Scholar]
- 83.Cabahug-Zuckerman P, et al. Potential role for a specialized β(3) integrin-based structure on osteocyte processes in bone mechanosensation. J. Orthop. Res. 2018;36:642–652. doi: 10.1002/jor.23792. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Litzenberger JB, Kim J-B, Tummala P, Jacobs CR. Beta1 integrins mediate mechanosensitive signaling pathways in osteocytes. Calcif. Tissue Int. 2010;86:325–332. doi: 10.1007/s00223-010-9343-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Haugh MG, Vaughan TJ, McNamara LM. The role of integrin alpha(V)beta(3) in osteocyte mechanotransduction. J. Mech. Behav. Biomed. Mater. 2015;42:67–75. doi: 10.1016/j.jmbbm.2014.11.001. [DOI] [PubMed] [Google Scholar]
- 86.Stephens LE, et al. Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes Dev. 1995;9:1883–1895. doi: 10.1101/gad.9.15.1883. [DOI] [PubMed] [Google Scholar]
- 87.Shekaran A, et al. The effect of conditional inactivation of beta 1 integrins using twist 2 Cre, Osterix Cre and osteocalcin Cre lines on skeletal phenotype. Bone. 2014;68:131–141. doi: 10.1016/j.bone.2014.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Litzenberger JB, Tang WJ, Castillo AB, Jacobs CR. Deletion of β1 integrins from cortical osteocytes reduces load-induced bone formation. Cell. Mol. Bioeng. 2009;2:416–424. doi: 10.1007/s12195-009-0068-4. [DOI] [Google Scholar]
- 89.Zimmerman D, Jin F, Leboy P, Hardy S, Damsky C. Impaired bone formation in transgenic mice resulting from altered integrin function in osteoblasts. Dev. Biol. 2000;220:2–15. doi: 10.1006/dbio.2000.9633. [DOI] [PubMed] [Google Scholar]
- 90.Smyth SS, Reis ED, Vaananen H, Zhang W, Coller BS. Variable protection of beta 3-integrin–deficient mice from thrombosis initiated by different mechanisms. Blood. 2001;98:1055–1062. doi: 10.1182/blood.V98.4.1055. [DOI] [PubMed] [Google Scholar]
- 91.Batra N, Kar R, Jiang JX. Gap junctions and hemichannels in signal transmission, function and development of bone. Biochim. Biophys. Acta. 2012;1818:1909–1918. doi: 10.1016/j.bbamem.2011.09.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Buo AM, Stains JP. Gap junctional regulation of signal transduction in bone cells. FEBS Lett. 2014;588:1315–1321. doi: 10.1016/j.febslet.2014.01.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Moorer MC, Stains JP. Connexin43 and the intercellular signaling network regulating skeletal remodeling. Curr. Osteoporos. Rep. 2017;15:24–31. doi: 10.1007/s11914-017-0345-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Lecanda F, et al. Connexin43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J. Cell Biol. 2000;151:931–944. doi: 10.1083/jcb.151.4.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Davis HM, et al. Disruption of the Cx43/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging. Aging Cell. 2017;16:551–563. doi: 10.1111/acel.12586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Chung DJ, et al. Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43. J. Cell Sci. 2006;119:4187–4198. doi: 10.1242/jcs.03162. [DOI] [PubMed] [Google Scholar]
- 97.Bivi N, et al. Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation. J. Bone Min. Res. 2012;27:374–389. doi: 10.1002/jbmr.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Grimston SK, Brodt MD, Silva MJ, Civitelli R. Attenuated response to in vivo mechanical loading in mice with conditional osteoblast ablation of the connexin43 gene (Gja1) J. Bone Min. Res. 2008;23:879–886. doi: 10.1359/jbmr.080222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Lloyd SA, Lewis GS, Zhang Y, Paul EM, Donahue HJ. Connexin 43 deficiency attenuates loss of trabecular bone and prevents suppression of cortical bone formation during unloading. J. Bone Min. Res. 2012;27:2359–2372. doi: 10.1002/jbmr.1687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Pacheco-Costa R, et al. Osteocytic connexin 43 is not required for the increase in bone mass induced by intermittent PTH administration in male mice. J. Musculoskelet. Neuronal Interact. 2016;16:45–57. [PMC free article] [PubMed] [Google Scholar]
- 101.Ma L, et al. Connexin 43 hemichannels protect bone loss during estrogen deficiency. Bone Res. 2019;7:11. doi: 10.1038/s41413-019-0050-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Cheng B, et al. Expression of functional gap junctions and regulation by fluid flow in osteocyte-like MLO-Y4 cells. J. Bone Min. Res. 2001;16:249–259. doi: 10.1359/jbmr.2001.16.2.249. [DOI] [PubMed] [Google Scholar]
- 103.Cheng B, et al. PGE(2) is essential for gap junction-mediated intercellular communication between osteocyte-like MLO-Y4 cells in response to mechanical strain. Endocrinology. 2001;142:3464–3473. doi: 10.1210/endo.142.8.8338. [DOI] [PubMed] [Google Scholar]
- 104.Alford AI, Jacobs CR, Donahue HJ. Oscillating fluid flow regulates gap junction communication in osteocytic MLO-Y4 cells by an ERK1/2 MAP kinase-dependent mechanism. Bone. 2003;33:64–70. doi: 10.1016/S8756-3282(03)00167-4. [DOI] [PubMed] [Google Scholar]
- 105.Cherian PP, et al. Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. Mol. Biol. Cell. 2005;16:3100–3106. doi: 10.1091/mbc.e04-10-0912. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Zhang D, et al. Extracellular matrix elasticity regulates osteocyte gap junction elongation: involvement of paxillin in intracellular signal transduction. Cell Physiol. Biochem. 2018;51:1013–1026. doi: 10.1159/000495482. [DOI] [PubMed] [Google Scholar]
- 107.Batra N, et al. Mechanical stress-activated integrin alpha5beta1 induces opening of connexin 43 hemichannels. Proc. Natl Acad. Sci. USA. 2012;109:3359–3364. doi: 10.1073/pnas.1115967109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Batra N, Jiang JX. “INTEGRINating” the connexin hemichannel function in bone osteocytes through the action of integrin α5. Commun. Integr. Biol. 2012;5:516–518. doi: 10.4161/cib.21322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Giepmans BN. Gap junctions and connexin-interacting proteins. Cardiovasc. Res. 2004;62:233–245. doi: 10.1016/j.cardiores.2003.12.009. [DOI] [PubMed] [Google Scholar]
- 110.Herve JC, Bourmeyster N, Sarrouilhe D, Duffy HS. Gap junctional complexes: from partners to functions. Prog. Biophys. Mol. Biol. 2007;94:29–65. doi: 10.1016/j.pbiomolbio.2007.03.010. [DOI] [PubMed] [Google Scholar]
- 111.Sorgen, P. L., Trease, A. J., Spagnol, G., Delmar, M. & Nielsen, M. S. Protein-protein interactions with connexin 43: regulation and function. Int. J. Mol. Sci.19, 1428 (2018). [DOI] [PMC free article] [PubMed]
- 112.Plotkin LI, Speacht TL, Donahue HJ. Cx43 and mechanotransduction in bone. Curr. Osteoporos. Rep. 2015;13:67–72. doi: 10.1007/s11914-015-0255-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Robling AG, Turner CH. Mechanical signaling for bone modeling and remodeling. Crit. Rev. Eukaryot. Gene Expr. 2009;19:319–338. doi: 10.1615/CritRevEukarGeneExpr.v19.i4.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Davidson RM, Tatakis DW, Auerbach AL. Multiple forms of mechanosensitive ion channels in osteoblast-like cells. Pflug. Arch. 1990;416:646–651. doi: 10.1007/BF00370609. [DOI] [PubMed] [Google Scholar]
- 115.Mikuni-Takagaki Y, Naruse K, Azuma Y, Miyauchi A. The role of calcium channels in osteocyte function. J. Musculoskelet. Neuronal Interact. 2002;2:252–255. [PubMed] [Google Scholar]
- 116.Yu K, et al. Mechanical loading disrupts osteocyte plasma membranes which initiates mechanosensation events in bone. J. Orthop. Res. 2018;36:653–662. doi: 10.1002/jor.23665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Rawlinson SC, Pitsillides AA, Lanyon LE. Involvement of different ion channels in osteoblasts’ and osteocytes’ early responses to mechanical strain. Bone. 1996;19:609–614. doi: 10.1016/S8756-3282(96)00260-8. [DOI] [PubMed] [Google Scholar]
- 118.Zhao Q, et al. Structure and mechanogating mechanism of the Piezo1 channel. Nature. 2018;554:487–492. doi: 10.1038/nature25743. [DOI] [PubMed] [Google Scholar]
- 119.Haselwandter, C. A. & MacKinnon, R. Piezo’s membrane footprint and its contribution to mechanosensitivity. Elife7, e41968 (2018). [DOI] [PMC free article] [PubMed]
- 120.Li, X. et al. Stimulation of Piezo1 by mechanical signals promotes bone anabolism. Elife8, e49631 (2019). [DOI] [PMC free article] [PubMed]
- 121.Sun, W. et al. The mechanosensitive Piezo1 channel is required for bone formation. Elife8, e47454 (2019). [DOI] [PMC free article] [PubMed]
- 122.Wang L, et al. Mechanical sensing protein PIEZO1 regulates bone homeostasis via osteoblast-osteoclast crosstalk. Nat. Commun. 2020;11:282. doi: 10.1038/s41467-019-14146-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Yang J, et al. Blocking glucocorticoid signaling in osteoblasts and osteocytes prevents mechanical unloading-induced cortical bone loss. Bone. 2020;130:115108. doi: 10.1016/j.bone.2019.115108. [DOI] [PubMed] [Google Scholar]
- 124.Sasaki F, et al. Mechanotransduction via the Piezo1-Akt pathway underlies Sost suppression in osteocytes. Biochem. Biophys. Res. Commun. 2020;521:806–813. doi: 10.1016/j.bbrc.2019.10.174. [DOI] [PubMed] [Google Scholar]
- 125.el Haj AJ, Walker LM, Preston MR, Publicover SJ. Mechanotransduction pathways in bone: calcium fluxes and the role of voltage-operated calcium channels. Med. Biol. Eng. Comput. 1999;37:403–409. doi: 10.1007/BF02513320. [DOI] [PubMed] [Google Scholar]
- 126.Thompson WR, et al. Association of the α2δ1 subunit with Cav3.2 enhances membrane expression and regulates mechanically induced ATP release in MLO-Y4 osteocytes. J. Bone Miner. Res. 2011;26:2125–2139. doi: 10.1002/jbmr.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127.Lu XL, Huo B, Chiang V, Guo XE. Osteocytic network is more responsive in calcium signaling than osteoblastic network under fluid flow. J. Bone Min. Res. 2012;27:563–574. doi: 10.1002/jbmr.1474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Huo B, et al. Fluid flow induced calcium response in bone cell network. Cell Mol. Bioeng. 2008;1:58–66. doi: 10.1007/s12195-008-0011-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Li J, Duncan RL, Burr DB, Turner CH. L-type calcium channels mediate mechanically induced bone formation in vivo. J. Bone Min. Res. 2002;17:1795–1800. doi: 10.1359/jbmr.2002.17.10.1795. [DOI] [PubMed] [Google Scholar]
- 130.Lewis KJ, et al. Osteocyte calcium signals encode strain magnitude and loading frequency in vivo. Proc. Natl Acad. Sci. USA. 2017;114:11775–11780. doi: 10.1073/pnas.1707863114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.van Oers RFM, Wang H, Bacabac RG. Osteocyte shape and mechanical loading. Curr. Osteoporos. Rep. 2015;13:61–66. doi: 10.1007/s11914-015-0256-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Wang X, Bank RA, TeKoppele JM, Agrawal CM. The role of collagen in determining bone mechanical properties. J. Orthop. Res. 2001;19:1021–1026. doi: 10.1016/S0736-0266(01)00047-X. [DOI] [PubMed] [Google Scholar]
- 133.Kerschnitzki M, et al. The organization of the osteocyte network mirrors the extracellular matrix orientation in bone. J. Struct. Biol. 2011;173:303–311. doi: 10.1016/j.jsb.2010.11.014. [DOI] [PubMed] [Google Scholar]
- 134.Matsugaki A, Isobe Y, Saku T, Nakano T. Quantitative regulation of bone-mimetic, oriented collagen/apatite matrix structure depends on the degree of osteoblast alignment on oriented collagen substrates. J. Biomed. Mater. Res. Part A. 2015;103:489–499. doi: 10.1002/jbm.a.35189. [DOI] [PubMed] [Google Scholar]
- 135.Shah FA, Zanghellini E, Matic A, Thomsen P, Palmquist A. The orientation of nanoscale apatite platelets in relation to osteoblastic-osteocyte lacunae on trabecular bone surface. Calcif. Tissue Int. 2016;98:193–205. doi: 10.1007/s00223-015-0072-8. [DOI] [PubMed] [Google Scholar]
- 136.Addison WN, et al. Extracellular matrix mineralization in murine MC3T3-E1 osteoblast cultures: an ultrastructural, compositional and comparative analysis with mouse bone. Bone. 2015;71:244–256. doi: 10.1016/j.bone.2014.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Burra S, Nicolella DP, Jiang JX. Dark horse in osteocyte biology. Communicative Integr. Biol. 2011;4:48–50. doi: 10.4161/cib.13646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 138.Wang L. Solute transport in the bone lacunar-canalicular system (LCS) Curr. Osteoporos. Rep. 2018;16:32–41. doi: 10.1007/s11914-018-0414-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Thompson WR, et al. Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone. J. Bone Min. Res. 2011;26:618–629. doi: 10.1002/jbmr.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Wijeratne SS, et al. Single molecule force measurements of perlecan/HSPG2: a key component of the osteocyte pericellular matrix. Matrix Biol. 2016;50:27–38. doi: 10.1016/j.matbio.2015.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141.Wang B, et al. Perlecan-containing pericellular matrix regulates solute transport and mechanosensing within the osteocyte lacunar-canalicular system. J. Bone Min. Res. 2014;29:878–891. doi: 10.1002/jbmr.2105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Pei S, et al. Perlecan/Hspg2 deficiency impairs bone’s calcium signaling and associated transcriptome in response to mechanical loading. Bone. 2020;131:115078. doi: 10.1016/j.bone.2019.115078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. Cell Biol. 2011;13:27–38. doi: 10.1038/nrm3254. [DOI] [PubMed] [Google Scholar]
- 144.Briscoe J, Thérond PP. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat. Rev. Mol. Cell Biol. 2013;14:416–429. doi: 10.1038/nrm3598. [DOI] [PubMed] [Google Scholar]
- 145.Andersson ER, Lendahl U. Therapeutic modulation of Notch signalling—are we there yet? Nat. Rev. Drug Discov. 2014;13:357–378. doi: 10.1038/nrd4252. [DOI] [PubMed] [Google Scholar]
- 146.Su N, Jin M, Chen L. Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models. Bone Res. 2014;2:14003. doi: 10.1038/boneres.2014.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 147.Rahman MS, Akhtar N, Jamil HM, Banik RS, Asaduzzaman SM. TGF-β/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation. Bone Res. 2015;3:15005. doi: 10.1038/boneres.2015.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148.Luo Z, et al. Notch signaling in osteogenesis, osteoclastogenesis, and angiogenesis. Am. J. Pathol. 2019;189:1495–1500. doi: 10.1016/j.ajpath.2019.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Laine CM, et al. WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta. N. Engl. J. Med. 2013;368:1809–1816. doi: 10.1056/NEJMoa1215458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Pyott SM, et al. WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta. Am. J. Hum. Genet. 2013;92:590–597. doi: 10.1016/j.ajhg.2013.02.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Maupin KA, Droscha CJ, Williams BO. A comprehensive overview of skeletal phenotypes associated with alterations in Wnt/β-catenin signaling in humans and mice. Bone Res. 2013;1:27–71. doi: 10.4248/BR201301004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 152.Burgers TA, Williams BO. Regulation of Wnt/β-catenin signaling within and from osteocytes. Bone. 2013;54:244–249. doi: 10.1016/j.bone.2013.02.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153.Bonewald LF, Johnson ML. Osteocytes, mechanosensing and Wnt signaling. Bone. 2008;42:606–615. doi: 10.1016/j.bone.2007.12.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154.Robinson JA, et al. Wnt/β-catenin signaling is a normal physiological response to mechanical loading in bone. J. Biol. Chem. 2006;281:31720–31728. doi: 10.1074/jbc.M602308200. [DOI] [PubMed] [Google Scholar]
- 155.Krishnan V, Bryant HU, MacDougald OA. Regulation of bone mass by Wnt signaling. J. Clin. Investig. 2006;116:1202–1209. doi: 10.1172/JCI28551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 156.Baron R, Rawadi G. Wnt signaling and the regulation of bone mass. Curr. Osteoporos. Rep. 2007;5:73–80. doi: 10.1007/s11914-007-0006-0. [DOI] [PubMed] [Google Scholar]
- 157.Sawakami K, et al. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J. Biol. Chem. 2006;281:23698–23711. doi: 10.1074/jbc.M601000200. [DOI] [PubMed] [Google Scholar]
- 158.Akhter MP, et al. Bone biomechanical properties in LRP5 mutant mice. Bone. 2004;35:162–169. doi: 10.1016/j.bone.2004.02.018. [DOI] [PubMed] [Google Scholar]
- 159.Saxon LK, Jackson BF, Sugiyama T, Lanyon LE, Price JS. Analysis of multiple bone responses to graded strains above functional levels, and to disuse, in mice in vivo show that the human Lrp5 G171V High Bone Mass mutation increases the osteogenic response to loading but that lack of Lrp5 activity reduces it. Bone. 2011;49:184–193. doi: 10.1016/j.bone.2011.03.683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160.Kang KS, Hong JM, Robling AG. Postnatal β-catenin deletion from Dmp1-expressing osteocytes/osteoblasts reduces structural adaptation to loading, but not periosteal load-induced bone formation. Bone. 2016;88:138–145. doi: 10.1016/j.bone.2016.04.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 161.Kramer I, et al. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Mol. Cell Biol. 2010;30:3071–3085. doi: 10.1128/MCB.01428-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 162.Maurel DB, et al. Beta-catenin haplo insufficient male mice do not lose bone in response to hindlimb unloading. PLoS ONE. 2016;11:e0158381. doi: 10.1371/journal.pone.0158381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 163.Javaheri B, et al. Deletion of a single β-catenin allele in osteocytes abolishes the bone anabolic response to loading. J. Bone Min. Res. 2014;29:705–715. doi: 10.1002/jbmr.2064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164.Kamel MA, Picconi Jl Fau - Lara-Castillo N, Lara-Castillo N Fau - Johnson ML, Johnson ML. Activation of beta-catenin signaling in MLO-Y4 osteocytic cells versus 2T3 osteoblastic cells by fluid flow shear stress and PGE2: Implications for the study of mechanosensation in bone. Bone. 2010;47:872–881. doi: 10.1016/j.bone.2010.08.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 165.Harburger DS, Calderwood DA. Integrin signalling at a glance. J. Cell Sci. 2009;122:159–163. doi: 10.1242/jcs.018093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 166.Zaidel-Bar R, Itzkovitz S, Ma’ayan A, Iyengar R, Geiger B. Functional atlas of the integrin adhesome. Nat. Cell Biol. 2007;9:858–867. doi: 10.1038/ncb0807-858. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167.Wu C, et al. Kindlin-2 controls TGF-β signalling and Sox9 expression to regulate chondrogenesis. Nat. Commun. 2015;6:7531. doi: 10.1038/ncomms8531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168.Cao H, et al. Focal adhesion protein Kindlin-2 regulates bone homeostasis in mice. Bone Res. 2020;8:2. doi: 10.1038/s41413-019-0073-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 169.Wang, Y. et al. Focal adhesion proteins Pinch1 and Pinch2 regulate bone homeostasis in mice. JCI insight4, e131692 (2019). [DOI] [PMC free article] [PubMed]
- 170.Turner CH, Forwood MR, Rho JY, Yoshikawa T. Mechanical loading thresholds for lamellar and woven bone formation. J. Bone Min. Res. 1994;9:87–97. doi: 10.1002/jbmr.5650090113. [DOI] [PubMed] [Google Scholar]
- 171.Sun C, et al. FAK promotes osteoblast progenitor cell proliferation and differentiation by enhancing Wnt signaling. J. Bone Min. Res. 2016;31:2227–2238. doi: 10.1002/jbmr.2908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 172.Plotkin LI, et al. Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs. Am. J. Physiol. Cell Physiol. 2005;289:C633–C643. doi: 10.1152/ajpcell.00278.2004. [DOI] [PubMed] [Google Scholar]
- 173.Cardoso L, et al. Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J. Bone Min. Res. 2009;24:597–605. doi: 10.1359/jbmr.081210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 174.Cabahug-Zuckerman P, et al. Osteocyte apoptosis caused by hindlimb unloading is required to trigger osteocyte RANKL production and subsequent resorption of cortical and trabecular bone in mice femurs. J. Bone Miner. Res. 2016;31:1356–1365. doi: 10.1002/jbmr.2807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 175.Verborgt O, Tatton NA, Majeska RJ, Schaffler MB. Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue: complementary roles in bone remodeling regulation? J. Bone Miner. Res. 2002;17:907–914. doi: 10.1359/jbmr.2002.17.5.907. [DOI] [PubMed] [Google Scholar]
- 176.Komori, T. Cell death in chondrocytes, osteoblasts, and osteocytes. Int. J. Mol. Sci.17, 2045 (2016). [DOI] [PMC free article] [PubMed]
- 177.Sherk VD, Rosen CJ. Senescent and apoptotic osteocytes and aging: exercise to the rescue? Bone. 2019;121:255–258. doi: 10.1016/j.bone.2019.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 178.Farr JN, et al. Identification of senescent cells in the bone microenvironment. J. Bone Min. Res. 2016;31:1920–1929. doi: 10.1002/jbmr.2892. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 179.Farr JN, Khosla S. Cellular senescence in bone. Bone. 2019;121:121–133. doi: 10.1016/j.bone.2019.01.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 180.Poole KE, et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J. 2005;19:1842–1844. doi: 10.1096/fj.05-4221fje. [DOI] [PubMed] [Google Scholar]
- 181.Li X, et al. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem. 2005;280:19883–19887. doi: 10.1074/jbc.M413274200. [DOI] [PubMed] [Google Scholar]
- 182.Sebastian A, Loots GG. Transcriptional control of Sost in bone. Bone. 2017;96:76–84. doi: 10.1016/j.bone.2016.10.009. [DOI] [PubMed] [Google Scholar]
- 183.Semenov M, Tamai K, He X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J. Biol. Chem. 2005;280:26770–26775. doi: 10.1074/jbc.M504308200. [DOI] [PubMed] [Google Scholar]
- 184.Lin C, et al. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J. Bone Min. Res. 2009;24:1651–1661. doi: 10.1359/jbmr.090411. [DOI] [PubMed] [Google Scholar]
- 185.Stegen S, et al. Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin. Nat. Commun. 2018;9:2557. doi: 10.1038/s41467-018-04679-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 186.Low BC, et al. YAP/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth. FEBS Lett. 2014;588:2663–2670. doi: 10.1016/j.febslet.2014.04.012. [DOI] [PubMed] [Google Scholar]
- 187.Dupont S, et al. Role of YAP/TAZ in mechanotransduction. Nature. 2011;474:179–183. doi: 10.1038/nature10137. [DOI] [PubMed] [Google Scholar]
- 188.Panciera T, Azzolin L, Cordenonsi M, Piccolo S. Mechanobiology of YAP and TAZ in physiology and disease. Nat. Rev. Mol. Cell Biol. 2017;18:758–770. doi: 10.1038/nrm.2017.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 189.Asaoka Y, Furutani-Seiki M. YAP mediated mechano-homeostasis—conditioning 3D animal body shape. Curr. Opin. Cell Biol. 2017;49:64–70. doi: 10.1016/j.ceb.2017.11.013. [DOI] [PubMed] [Google Scholar]
- 190.Xiong J, Almeida M, O’Brien CA. The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation. Bone. 2018;112:1–9. doi: 10.1016/j.bone.2018.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 191.Tang Y, et al. MT1-MMP-dependent control of skeletal stem cell commitment via a β1-integrin/YAP/TAZ signaling axis. Dev. Cell. 2013;25:402–416. doi: 10.1016/j.devcel.2013.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 192.Kegelman CD, et al. Skeletal cell YAP and TAZ combinatorially promote bone development. FASEB J. 2018;32:2706–2721. doi: 10.1096/fj.201700872R. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 193.Kegelman, C. D. et al. YAP and TAZ mediate osteocyte perilacunar/canalicular remodeling. J. Bone Miner. Res.35, 196–210 (2020). [DOI] [PMC free article] [PubMed]
- 194.Langdahl BL, et al. Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial. Lancet. 2017;390:1585–1594. doi: 10.1016/S0140-6736(17)31613-6. [DOI] [PubMed] [Google Scholar]
- 195.Prasadam I, et al. Impact of extracellular matrix derived from osteoarthritis subchondral bone osteoblasts on osteocytes: role of integrinbeta1 and focal adhesion kinase signaling cues. Arthritis Res. Ther. 2013;15:R150. doi: 10.1186/ar4333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 196.Claes L, Recknagel S, Ignatius A. Fracture healing under healthy and inflammatory conditions. Nat. Rev. Rheumatol. 2012;8:133–143. doi: 10.1038/nrrheum.2012.1. [DOI] [PubMed] [Google Scholar]
- 197.Metzger CE, Narayanan SA. The role of osteocytes in inflammatory bone loss. Front. Endocrinol. 2019;10:285. doi: 10.3389/fendo.2019.00285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 198.Wang, W., Sarazin, B. A., Kornilowicz, G. & Lynch, M. E. Mechanically-loaded breast cancer cells modify osteocyte mechanosensitivity by secreting factors that increase osteocyte dendrite formation and downstream resorption. Front. Endocrinol.9, 352 (2018). [DOI] [PMC free article] [PubMed]
- 199.Ross, M. H. et al. Bone-induced expression of integrin β3 enables targeted nanotherapy of breast cancer metastases. Cancer Res. 77, 6299–6312 (2017). [DOI] [PMC free article] [PubMed]
- 200.Holguin N, Brodt MD, Silva MJ. Activation of Wnt signaling by mechanical loading is impaired in the bone of old mice. J. Bone Miner. Res. 2016;31:2215–2226. doi: 10.1002/jbmr.2900. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 201.Hemmatian H, Bakker AD, Klein-Nulend J, van Lenthe GH. Aging, osteocytes, and mechanotransduction. Curr. Osteoporos. Rep. 2017;15:401–411. doi: 10.1007/s11914-017-0402-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 202.Findlay DM, Kuliwaba JS. Bone–cartilage crosstalk: a conversation for understanding osteoarthritis. Bone Res. 2016;4:16028. doi: 10.1038/boneres.2016.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 203.Jaiprakash A, et al. Phenotypic characterization of osteoarthritic osteocytes from the sclerotic zones: a possible pathological role in subchondral bone sclerosis. Int. J. Biol. Sci. 2012;8:406–417. doi: 10.7150/ijbs.4221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 204.Wen CY, et al. Collagen fibril stiffening in osteoarthritic cartilage of human beings revealed by atomic force microscopy. Osteoarthr. Cartil. 2012;20:916–922. doi: 10.1016/j.joca.2012.04.018. [DOI] [PubMed] [Google Scholar]
- 205.Gao, H. et al. Lipoatrophy and metabolic disturbance in mice with adipose-specific deletion of kindlin-2. JCI Insight4, e128405 (2019). [DOI] [PMC free article] [PubMed]
- 206.Upadhyay J, Farr OM, Mantzoros CS. The role of leptin in regulating bone metabolism. Metabolism. 2015;64:105–113. doi: 10.1016/j.metabol.2014.10.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 207.Lories RJ, et al. Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum. 2007;56:4095–4103. doi: 10.1002/art.23137. [DOI] [PubMed] [Google Scholar]
- 208.Mosley JR, Lanyon LE. Strain rate as a controlling influence on adaptive modeling in response to dynamic loading of the ulna in growing male rats. Bone. 1998;23:313–318. doi: 10.1016/S8756-3282(98)00113-6. [DOI] [PubMed] [Google Scholar]
- 209.Mosley JR, March BM, Lynch J, Lanyon LE. Strain magnitude related changes in whole bone architecture in growing rats. Bone. 1997;20:191–198. doi: 10.1016/S8756-3282(96)00385-7. [DOI] [PubMed] [Google Scholar]
- 210.Bonnet N, et al. The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activity. J. Biol. Chem. 2009;284:35939–35950. doi: 10.1074/jbc.M109.060335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 211.Akhter MP, Cullen DM, Pedersen EA, Kimmel DB, Recker RR. Bone response to in vivo mechanical loading in two breeds of mice. Calcif. Tissue Int. 1998;63:442–449. doi: 10.1007/s002239900554. [DOI] [PubMed] [Google Scholar]
- 212.Moustafa A, et al. Mechanical loading-related changes in osteocyte sclerostin expression in mice are more closely associated with the subsequent osteogenic response than the peak strains engendered. Osteoporos. Int. 2012;23:1225–1234. doi: 10.1007/s00198-011-1656-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 213.Sugiyama T, et al. Mechanical loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on trabecular and cortical bone in mice. Bone. 2008;43:238–248. doi: 10.1016/j.bone.2008.04.012. [DOI] [PubMed] [Google Scholar]
- 214.Rucci N, et al. Lipocalin 2: a new mechanoresponding gene regulating bone homeostasis. J. Bone Min. Res. 2015;30:357–368. doi: 10.1002/jbmr.2341. [DOI] [PubMed] [Google Scholar]
- 215.Baehr LM, et al. Muscle-specific and age-related changes in protein synthesis and protein degradation in response to hindlimb unloading in rats. J. Appl Physiol. 2017;122:1336–1350. doi: 10.1152/japplphysiol.00703.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 216.Ajubi NE, Klein-Nulend J, Alblas MJ, Burger EH, Nijweide PJ. Signal transduction pathways involved in fluid flow-induced PGE2 production by cultured osteocytes. Am. J. Physiol. 1999;276:E171–E178. doi: 10.1152/ajpendo.1999.276.1.E171. [DOI] [PubMed] [Google Scholar]
- 217.Joldersma M, Burger EH, Semeins CM, Klein-Nulend J. Mechanical stress induces COX-2 mRNA expression in bone cells from elderly women. J. Biomech. 2000;33:53–61. doi: 10.1016/S0021-9290(99)00172-4. [DOI] [PubMed] [Google Scholar]
- 218.Kulkarni RN, Bakker AD, Everts V, Klein-Nulend J. Inhibition of osteoclastogenesis by mechanically loaded osteocytes: involvement of MEPE. Calcif. Tissue Int. 2010;87:461–468. doi: 10.1007/s00223-010-9407-7. [DOI] [PMC free article] [PubMed] [Google Scholar]